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Pressure ulcers are injury to skin and underlying tissues caused by constant pressure 
(Reilly et al., 2007).  The breakdown of skin occurs from an insufficient blood supply to these 
cells, typically at bony prominences (Smeltzer et al., 2008, Brindle & Wegelin 2012).  Any 
prolonged and unrelieved pressure causes an occlusion of blood flow, ischemia, and ultimately 
cell death (Salcido et al., 2007). Iatrogenic pressure ulcers that occur during hospitalization are 
called Hospital-Acquired Pressure Ulcers, or HAPU. 
HAPUs are a significant problem in patient care and have deleterious implications for the 
patient and the healthcare system.  The development of pressure ulcers increases the length of 
hospital stay on average by 4 days (Calianno, 2007b).  Between 1999 and 2003 a 63% increase 
in length of stay occurred in which pressure ulcers were a listed diagnosis in patient medical 
records (Calianno, 2007b).  Among patients with pressure ulcers, self-reports described an 
increase in pain and suffering (Pieper et al., 2009). Pressure ulcers complicated the healing 
process and increased the mortality likelihood for hospitalized patients, which were reported as 
the cause of death for 115,000 individuals between 1990 and 2001 (AHRQ, 2013; Brem et al., 
2010).  Estimates for prevalence range from 0.4% to 38% in acute care hospitals (AHRQ, 2013).  
The estimated cost of pressure ulcers in the United States ranges from $2.2 to $3.6 billion a year 
(Calianno 2007a, 2007b), with a mean cost of $43,180 per hospitalization (Department of Health 
and Human Services (DHHS) 2008).  Effective October 1, 2008, The Centers for Medicare and 
Medicaid Services (CMS) no longer reimburse hospitals for treating Stage III or IV HAPUs 
(Calianno 2007a, 2007b; Berquist-Beringer et al., 2009).  Stage III and IV HAPU reported in 
2008 to the Department of Health and Human Services totaled 257, 412 events (DHHS, 2008).  
With the devastating effects to patients and healthcare institutions, nursing is challenged with 
identifying innovative ways to prevent HAPU.  The debilitated hospitalized patient with acute 
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and chronic multisystem failure is at greatest risk for skin breakdown, and our role as bedside 
clinicians is to identify risk factors and reverse pressure-related skin changes through prevention 
(Calianno 2007a).   
The overall purpose of this practice inquiry is to implement a HAPU prevention program 
at TriHealth, a healthcare organization in Cincinnati, Ohio, and evaluate an emerging preventive 
strategy utilizing a high-risk assessment tool and intervening with a soft silicone foam-bordered 
dressing (Mepilex® Border Sacrum, Mölnlycke Health Care) to reduce HAPU development.  
The first manuscript is a review of the studies published between 2010 and 2014 that have 
utilized Mepilex® dressings in adult inpatient hospitals as an effective intervention for the 
prevention of HAPUs in acutely ill populations.  The findings from this review provided 
evidence to support nursing interventions to identify high-risk critically ill patients and initiate 
additional prophylaxis above and beyond the nursing standards of care to prevent HAPU 
formation.  Subsequently, these evidence-based recommendations helped direct a research study 
assessing the high-risk characteristics associated with skin breakdown and HAPU formation 
among critically ill adult patients at Bethesda North Hospital (Intensive Care Unit) using a 
preventive Mepilex® dressing.  The focus of the second manuscript was to determine if any 
hospital- specific and/or patient-specific variables were associated with skin breakdown and 
HAPU formation.  Additionally, the second manuscript suggests that prophylactic application of 
Mepilex® dressings may be effective in HAPU reduction.  The impetus of a potentially new 
assessment tool for assessing acutely ill patients for high-risk variables for skin breakdown 
supported changing clinical practice guidelines for the prevention of HAPU.  The evidence from 
manuscript two, demonstrating early identification of high-risk criteria among acutely ill patients 
and the adjunctive use of Mepilex® dressings to prevent skin breakdown and HAPU formation, 
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was adopted into TriHealth’s Pressure Ulcers: Guidelines for Prevention and Treatment policy.  
The purpose of the final manuscript is to evaluate the implementation of these new guidelines via 
analysis of the change in nursing knowledge before and after an education didactic on the 
changes implemented, and the change in nursing clinical behaviors, i.e. are the nurses adhering 
to the new guidelines, through a retrospective medical record review of nursing documentation 
throughout the TriHealth organization. 
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Abstract 
Hospital-Acquired Pressure Ulcers (HAPUs) are a significant healthcare problem in the United 
States.  HAPU increase the length of hospital stays, patient pain and suffering, complications in 
the healing process, and mortality and morbidity, as well as healthcare costs, which are estimated 
to be 2.2 to 3.6 billion dollars annually.  Insurance provider reimbursement has greatly become 
dependent on patient outcomes, with HAPUs considered to be a result of poor quality nursing 
care.  As of 2008, Stage III and IV pressure ulcers are no longer reimbursable, resulting in 
healthcare organizations’ implementation of pressure ulcer prevention guidelines and 
interventions to prevent HAPU formation.  New evidence, reporting varied degrees of success, 
has emerged utilizing soft silicone foam bordered dressings (Mepilex®) as an adjunctive 
prevention therapy for pressure ulcer formation.  The purpose of this paper is to review the 
studies published between 2010 and 2014 that describe the use of Mepilex® dressings for HAPU 
prevention.  Six studies met inclusion criteria.  Findings suggest that Mepilex® dressings 
produce clinically relevant reduction in HAPU incidence and prevalence, and further recommend 
healthcare organizations benefiting from implementing protocols to include Mepilex® dressing 
application to patients at risk for skin breakdown.   
Keywords:  Pressure Ulcer, Hospital Acquired Pressure Ulcer (HAPU), Mepilex®, soft 
silicone foam border dressing, prevention 
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A Literature Review of Mepilex® Dressings to Prevent Hospital Acquired Pressure Ulcers 
Introduction 
Problem Focus 
Pressure ulcers are wounds caused by constant pressure to underlying skin tissue (Reilly, 
Karakousis, Schrag, & Stawicki, 2007).  The breakdown of skin occurs from an insufficient 
blood supply, typically at bony prominences, most commonly the sacrum (Smeltzer, Bare, 
Hinkle, & Cheever, 2008; Brindle & Wegelin, 2012).  The prolonged and unrelieved pressure on 
skin causes an occlusion of blood flow, ischemia, and ultimately cell death (Salcido, Popescu, & 
Ahn, 2007).  Pressure ulcers occurring during a stay within a medical facility are deemed to be 
hospital-acquired pressure ulcers (HAPU).  HAPU increase the length of hospital stays, patient 
pain and suffering, complications in the healing process, potential death, as well as health care 
costs (Armstrong et al., 2008).  The estimated cost of HAPU in the United States ranges from 
$2.2 to $3.6 billion a year (Calianno, 2007a; Calianno, 2007b) with the mean cost of $43,180 per 
hospital stay (Department of Health and Human Services, 2008).  
Population of Interest 
Identification of patients at risk for HAPU development is important for prevention 
initiatives.  In a literature review, McGough (1999) reported over 40 different pressure ulcer 
prevention assessment tools.  It was concluded that none of these tools were consistently reliable 
for all clinical situations (i.e. different patient groups have different clinical needs and pressure 
ulcer prevention tools should be used in the appropriate clinical setting).  In the acutely ill 
population, early identification of patient characteristics, comorbid risk factors, and inpatient 
care interventions and therapies are needed to isolate those at high-risk, and implement evidence-
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based preventive strategies to reduce incidence of pressure ulcer formation, therefore the adult 
acutely ill individual will be the target population for this literature review (Reilly et al., 2007; 
Cox 2011). 
Purpose of the Review 
With the devastating effects to patients and healthcare institutions, nursing is challenged 
with early identification of high-risk patients, and implementing innovative ways to prevent 
HAPU above traditional standards of care to improve patient outcomes. With high prevalence 
rates at our healthcare organization, a quality improvement project was initiated to identify 
strategies to reduce HAPU rates in the medical-surgical intensive care unit (MSICU).  At this 
time, an important preventive strategy using a soft silicone foam-bordered dressing (Mepilex® 
Border Sacrum, Mölnlycke Health Care) was a novel preventive approach to this clinical 
problem.  The Skin Care Committee responsible for HAPU prevention and treatment at our 
organization, along with the author of this article, questioned the reliability and validity of 
prophylactic dressing using among acutely ill populations.  Thus, we formulated the PICOT 
question for this inquiry;  ‘among adult acutely ill hospitalized patients, does the use of sacral 
prophylactic silicone foam dressings compared to individuals receiving standard of care 
preventative measures, reduce the prevalence of hospital acquired pressure ulcers?’ 
  The purpose of this review paper is to compile and evaluate the research evidence 
supporting the use of Mepilex® dressings as an effective intervention for the prevention of 
HAPUs in the acutely ill population.  The literature will be analyzed including a critique of the 
methodological design and articulation of the strengths and gaps within the current literature.  
From this review, we will formulate an estimate of usefulness to the proposed clinical problem 
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with recommendations to nursing practice. Recommendations from supporting evidence suggest 
nursing interventions to include early identification of high-risk acutely ill patients and initiate 
additional prophylaxis above and beyond the nursing standards of care to prevent pressure ulcer 
formation.  Subsequently, the evidence-based review may translate into changes in hospital 
policy that dictate the use of Mepilex® dressings as a standard of care not only for critically ill 
patients but for all patients admitted to the hospital.   
Literature Review 
Systematic Approach 
The U.S. National Library of Medicine National Institutes of Health (PubMed) and 
Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases were searched 
for the reported use of a Mepilex® Border dressing as a prophylactic measure to prevent HAPU 
development.  The search was limited from 2000 to 2014, English-language, and adult human 
Intensive Care Unit (ICU) subjects.  Articles were selected if the Mepilex® dressing was used on 
critically ill or ICU patients with no pre-existing pressure ulcer upon admission to the hospital, 
and excluded if the Mepilex® dressing was used as a treatment intervention for patients with 
pressure ulcers or medical conditions of the sacralcoccygeal area. Programs that evaluated other 
preventive interventions such as specialty bed mattresses or other skin care products such as 
creams or medications were eliminated from this review.  To refine the search, studies were 
excluded if they weren’t available in English language. 
Six articles met criteria and were used for this literature review.  The breakdown of 
articles include a randomized control trial (RCT) (n=1), retrospective descriptive studies (n=2), 
and non-randomized prospective control trials (n=3).  Literature synthesis of these articles will 
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evaluate the research process and the synthesis of research findings for 1) acutely ill patient 
characteristics and risk factors for pressure ulcer development, 2) current recommendations for 
pressure ulcer prevention and 3) interventions to reduce HAPU incidence, specifically studies 
whose intervention utilize Mepilex® Border Sacrum dressings as a prophylactic device.   
Summary of Evidence 
Comprehensive Summary of Relevant Literature 
The Centers for Medicare and Medicaid Services ‘never-event’ payment provisions for 
HAPU reimbursement require healthcare providers to develop pressure ulcer prevention 
strategies and interventions for professional advancement, quality patient care, and financial 
survival.  The suggested preventive strategies include patient education, clinician training, 
developing communication and terminology materials, implementing toolkits and protocols, and 
healthcare and patient provider adherence to policies and standards of care.  The literature 
identified integrating the components of simplification and standardization of pressure ulcer 
interventions and documentation as ways to improve process of care (Armstrong et al., 2008; 
Sullivan & Schoelle, 2013).  In addition to providing preventive strategies, clinicians must be 
able to identify patients deemed at risk of skin breakdown.  Numerous patient characteristics and 
ICU-based variables were associated with skin breakdown; however, the key implication derived 
from these specific studies suggested that understanding these high-risk factors is important for 
early detection.  Current risk assessment tools may not accurately incorporate these ICU specific 
variables, thus development of an ICU specific risk assessment tool could be warranted (Bours, 
De Laat, Halfens, & Lubbers, 2001; Nijs et al., 2008; Cox, 2011).   
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The six studies recognized a novel approach in preventing ulcers by using an absorbent 
soft, silicone, self-adherent, foam border dressing in the sacral area before pressure ulcers 
develop (Brindle, 2010; Butcher & Thompson, 2010; Brindle & Wegelin, 2012; Chaiken, 2012; 
Walsh, et al., 2012; Cubit, McNally, & Lopez, 2013; Santamaria et al., 2013).  Brindle (2010) 
performed a research study utilizing absorbent soft silicone self-adherent dressings in a surgical-
trauma ICU.  Of the 41 identified high-risk patients that received the preventive sacral dressing, 
there was a zero percent pressure ulcer incidence in the treatment group.  A subsequent study 
comparing a preventive Mepilex® group (n=50) to a standard care group (n=35) resulted in a 
reduced pressure ulcer incidence in the treatment group (Brindle & Wegelin, 2012). Chaiken 
(2012) and Walsh et al. (2012) reported reduced pressure ulcer incidence when the Mepilex® 
dressing was applied to patients during quality improvement initiatives.  Similarly a study of 
early preventive intervention to utilize the sacral Mepilex® among individuals admitted through 
the emergency department (ED) supports the findings of reduced HAPU incidence (Cubit, et al., 
2012). More recently, a RCT in Australia demonstrated statistically and clinically relevant 
reduction of heel and sacral pressure incidence by 10% between the Mepilex® intervention 
(n=219) and control groups (n=221) (Santamaria et al., 2012). 
Sampling  
 The samples included in this literature review include adult patients admitted to the ICU.  
Sampling was based on a convenience sample from the respective ICU setting or known 
admission to the ICU.  Three of the studies used eligibility inclusion identifiers based on a 
criterion checklist developed by Brindle (Brindle, 2010; Brindle & Wegelin, 2012; Walsh et al., 
2012).  One study initiated the intervention in the Emergency Department (ED) on patients 
knowingly admitted to the ICU (Santamaria et al., 2013).  The studies lack an analysis of power 
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to determine effect size of the sample, apart from the RCT with a determined power of 220 
individuals per group (Santamaria et al., 2013).  The smallest intervention group produced a 
sampling size of 41 participants with the largest group having 440 participants.  
 One potential drawback to the studies’ sampling plans was the size of the samples.  Small 
sample sizes can reduce the representation of the population of interest and produce a sampling 
bias from over or under-representation.  The studies within this review may over-represent the 
risk of HAPU formation alone just from the acuity of illness associated with ICU settings, i.e. the 
more sick the patient the increased risk of HAPU. Demographic variables were limitedly 
reported to demonstrate homogeneity of the populations studied.  ICU-specific covariates that 
were statistically supportive of pressure ulcer development included history of vascular disease, 
vasopressor use such as Dopamine, Dobutamine, Norepinephrine, dialysis, infection, length of 
stay, age, total Braden score, level of mobility and friction/shear (Bours et al., 2001; Nijs, 2008; 
Cox, 2012). 
Research Design 
 Chaiken (2012) and Walsh et al. (2012) studied the effect of silicone foam dressing on 
HAPU incidence using a non-experimental observational design.  A standard for comparison 
between HAPU formation between the intervention and control group involved the use of 
incidence or prevalence data.   Both studies obtained historical data on HAPU incidence or 
prevalence for their unit, and then prospectively applied the silicone dressing to all patients 
admitted to their intensive care unit (ICU).  Incidence rates were tracked during the prospective 
data collection timeframe, and then compared to the retrospective historical data.  The research 
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design lacks any regard to any confounding characteristics between the pre-intervention group to 
the post-intervention group for similarity, acuity, or healthcare therapies received. 
Three studies were quasi-experimental controlled trials without randomization (Brindle, 
2010; Brindle & Wegelin, 2012; Cubit et al., 2012). The quasi-experimental design was intended 
to compare the intervention outcomes with the independent variable to establish causality.  While 
the quasi-experimental studies included an intervention and used a comparison group as a 
control, these studies lacked randomization and blindness. In the more recent publication Brindle 
and Wegelin (2012) offered a pseudo-randomization of the participants and investigators by 
blinding room assignments post-operatively as intervention rooms versus standard care rooms.  
Brindle (2010) and Brindle and Wegelin (2012) suggested that a large randomized control trial is 
needed to truly determine if the reduction in HAPU incidence is related to this dressing or to an 
extraneous variable.  Santamaria et al., (2013) did such a study with randomization of individuals 
in the ED by designating the control and intervention group through a pre-prepared series of 
envelopes randomized by a computer-generated set of numbers to allocate to each patient.  
Methods to Data Collection 
 Several of the studies relied on the assessment skills, knowledge, and expertise of staff 
nurses to accurately implement the intervention, assess findings, and alert the research team of 
any skin alterations, while some of the study designs were executed by the research team 
entirely.  The influence of staff nurse involvement poses concern about whether such 
involvement could influence data quality or study outcomes. All studies acknowledge that prior 
to initiation ICU staff nurses were educated on the application of the dressing, HAPU education 
and training, and review of the standards of care for preventive skin interventions such as 
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turning, repositioning, risk assessment tool documentation, etc.  Chaiken (2012) suggest that the 
influence of the research team’s education and encouragement could have increased the 
compliance towards the standards of care for skin prevention, thus a potential extraneous 
variable influencing the data towards reduced HAPU incidence.  
Brindle and Wegelin (2012) and Cubit et al’s (2012) experimental studies required a 
specialized data collection form to be created to capture all the covariates of interest and the skin 
assessment identifying pressure ulcers.  These tools allowed staff nurses to indicate nominal 
inclusion criteria applicable to the participant, interventions that were completed, and 
demographic information at the time of data collection.  Strengths of these tools include the ease 
of use to staff nurses and capturing the information needed to achieve the goals of the study. 
However there was no indication or report of pre-testing for validity, reliability, sensitivity, 
specificity, or fidelity. The remaining studies collected relevant data through retrospective and 
prospective audits of the patients’ charts and electronic medical records.   
Findings 
 The findings of the studies all demonstrate lower HAPU incidence in the intervention 
group utilizing the silicone dressing compared to the control group only receiving standard skin 
care prevention practices.  Table 1 summarizes the HAPU incidence rates resulted in the studies 
with the greatest of incidence difference of 11.5% (Brindle, 2010). 
Brindle and Wegelin (2012) deliver the most in depth analysis of their data.  Twenty-one 
covariates derived from eligibility criteria and patient characteristics demonstrated no 
statistically significant differences between the intervention group and the control group with all 
p-values greater than 0.058, which is supportive of the notion that the samples in each group 
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were similar in acuity of illness and characteristics.  A representative sample suggests that the 
reduced HAPU incidence is related to the silicone dressing.  Hazard ratios were calculated to 
compare the two groups with regard to risk of pressure ulcer formation, and after adjustment 
were made to equilibrate severity between groups, the standard care individuals were 3.6 times 
more at risk over time to develop a pressure ulcer than those with a preventative Mepilex® 
applied to their sacrum.  However, the hazard ration of 3.6 was not statistically significant with 
achieving a p-value of 0.296.  Similarly, Santamaria et al. (2013) assessed patient variables and 
demographics, but no analyses were computed to determine an association between the 
covariates and pressure ulcer formation, however, a calculated hazard ratio of 0.19 between 
groups was determined, which was statistically significant achieving a p-value of 0.002.  To 
further support the association of the Mepilex® innovation Cubit et al., (2012) identified his 
control group at 5.4 times increased risk for pressure ulcer injury than those receiving the 
prophylactic dressing.   
Limitations, Strengths, & Gaps 
 Evidence related to pressure ulcers is abundantly available for etiologies, prevention, and 
treatment.  Traditionally, Mepilex® dressing use has been known as an evidence-based treatment 
intervention for individuals with pressure ulcers. A limitation to the research includes very little 
knowledge on prophylactic Mepilex® dressings used to prevent HAPU from occurring.   The 
articles presented in this review are the only published findings regarding this concept.  Future 
studies are needed, with larger sample size and randomization, to provide sound statistical 
support that a silicone dressing does reduce HAPU incidence.  Specific to the articles analyzed in 
this review, the general limitations include small sampling sizes, minimal statistical analysis, and 
the potential of numerous extraneous variables (covariates) that need analysis into their influence 
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of HAPU formation.  Since the inception of this idea, no other study exists using an alternate 
type of dressing.  Only the Mepilex® Border dressing has been used and the question exists if a 
different dressing could produce similar results or even better.  The authors in this literature 
review report a limitation to their study regarding the influence of the education and training of 
the staff nurse regarding HAPUs and may have increased compliance and diffusion of the 
standards of care, thus an additional source towards HAPU prevention, and should be considered 
in future studies.  Another limitation introduced in these studies in the influence of self-reporting 
from staff nurses.  Several of the studies relied on the documentation of the nurses, thus self-
reporting, of their assessment and interventions.  This introduces bias, possible under/over 
estimation of the problem, and potential for nursing to simply be mistaken or misremembered the 
assessment and interventions provided for the patient.  Self-reporting reduces the validity of the 
results. 
The strength of these studies is the reproducibility to demonstrate a reduction of pressure 
ulcer incidence, as seen in all of the studies included in this review. Replication trials continue to 
show differences in HAPU incidence between the control and intervention groups, and are 
suggestive that the Mepilex® dressing may be influencing these findings.  Being able to prevent 
a pressure ulcer for our patients equates to less patient pain and suffering, shorter hospitalization 
times, and decreased healthcare costs.  This begs to answer the practical question for nurses to 
perform clinically simple and relatively cost neutral intervention to reduce HAPU formation 
when the evidence does not statistically support it.  A fiduciary benefit might be implied by 
Chaiken (2012), who reported a total cost of the silicone dressing during the 6-month period of 
$6,653.00 (n=273). While this is only one figure of the financial burden of using the silicone 
dressing preventatively, as reported, the average cost to treat a HAPU is $43,180 (Department of 
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Health and Human Services, 2008).  A cost-benefit analysis of monies saved as a result of using 
the Mepilex® dressing rather than money spent for pressure ulcer treatment may be warranted 
and support the acceptance of this practice.  The potential financial incentive to healthcare 
institutions, insurance reimbursement, and patient costs can be considered as strengths to this 
innovation. 
Recommendations for Practice 
As healthcare requirements become more stringent and reimbursement reliant upon 
quality patient outcomes, the use of the Mepilex® dressing may be an easy solution to a large 
problem.  The articles from this review are suggestive that the use of prophylactic silicone 
dressings may be effective at HAPU prevention as seen through reduction of incidence scores.  
Similar findings replicated in these studies provide further support that the Mepilex® dressing 
may reduce HAPU incidence, unfortunately very limited descriptive and inferential statistics 
exist from only one RCT to defend the causality. Despite the limited statistical support, the 
clinical practicality to use Mepilex® to reduce new cases of iatrogenic pressure ulcers exists, and 
based on what evidence is available a change in nursing practice is recommended to 1) utilize an 
assessment tool to better identify patients at risk and 2) prophylactically use a silicone foam 
dressing on acutely ill patients admitted to hospitals.  
The authors of this literature review support the use of a silicone dressing as an additional 
measure for pressure ulcer prevention and have adopted the practice into their preventative 
standards of care.  It should be noted that these studies consistently recommend the routine use 
of a Mepilex® dressing should not be the only intervention used to reduce HAPU in the ICU, 
however, it should be considered as an adjunctive therapy when traditional preventative 
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interventions alone prove ineffective or only partly effective (Chaiken, 2012).  Brindle (2010) 
comments that nurses must rely on their bedside skills and not on the application of the 
Mepilex® dressing, in that it does not replace quality nursing care.  The Mepilex® can serve as 
an adjunct to reduce pressure ulcer formation and enhance patient outcomes.  Santamaria et al., 
(2013) study produced substantial support with their RCT that resulted in policy and procedural 
mandates within their institution, and evidence from Cubit et al., (2012) envisages identification 
and application of Mepilex® dressings at early stages of the patient’s hospitalization, for 
instance in the ED.  Standardization of prophylactic Mepilex® dressings on acutely ill patients is 
recommended based on the current evidence available, and hospital organizations should 
implement policies to include these recommendations as additional preventive measures.  
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Table 1:  
 Literature Review HAPU Incidence (%) Reported 
*Prevalence 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
Incidence Brindle 
(2010) 
Chaiken 
(2012) 
Walsh et al. 
(2012) 
Brindle & 
Wegelin 
(2012) 
Cubit et al. 
(2012) 
Santamaria et 
al. (2013) 
Comparison 11.5% 12.3%* 12.5% 11% 10.3% 13.1% 
Intervention 0% 1.8% 7% 2% 1.96% 3.1% 
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Abstract 
Aim & Objectives: To examine factors associated with skin breakdown and pressure ulcer 
development among critically ill patients to whom Mepilex®, a prophylactic silicone dressing, 
for the prevention of sacral pressure ulcers, had been applied.   
Background:  Recent studies have begun to understand factors associated with the risk for skin 
breakdown among hospitalized critically ill patients.  Several studies have shown favorable 
reduction in pressure ulcers when prophylactic silicone dressings were applied to high-risk 
individuals; however there is much to be learned regarding the factors associated with pressure 
ulcers among critically ill patients. Understanding such factors is important for the development 
of evidence-based risk assessment tools specific for intensive care unit patients. 
Design:  Prospective longitudinal study 
Methods: Data collection occurred March 1-May 31, 2012 among patients admitted to the 
Intensive Care Unit (ICU). Variables including patient demographics, the criteria for applying a 
Mepilex®, Braden Scale score, primary diagnoses and comorbidities, body mass index, and 
length of hospitalization and days in the ICU were collected. Univariate logistic regression 
analyses were performed to determine the association between study variables and skin 
breakdown.  
Results:  47 patients enrolled in the study.  Two developed sacral pressure ulcers and 20 had 
skin breakdown in other locations.  Characteristics contributing to skin breakdown included 
associated respiratory or cardiac diagnosis, being on a ventilator > 12 hours, using 
sedation/paralytics, using restraints, being on continuous renal replacement therapy, and having a 
Braden score ≤ 12. 
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Conclusions: The identified variables may be important in understanding risk factors for skin 
breakdown leading to pressure ulcers, and may be considered additional criteria in a pressure 
ulcer risk assessment tool among ICU patients. 
Relevance to Clinical Practice:  Individuals with the identified variables may be at greater risk 
for pressure ulcers and may benefit from prophylactic silicone dressings. 
Keywords: Pressure ulcer risk factors, Mepilex®, hospital acquired pressure ulcer, HAPU, 
prevention, silicone dressing, skin breakdown 
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Factors associated with risk of skin breakdown and pressure ulcer formation among individuals 
in the intensive care unit with a sacral Mepilex® dressing during a HAPU quality improvement 
project 
 
Introduction 
Hospital acquired pressure ulcers (HAPU) are a significant problem in patient care.  The 
development of pressure ulcers can increase the length of hospital stays, patient pain and 
suffering, complications in the healing process, potential death, as well as increase health care 
costs (Armstrong et al. 2008).  The estimated cost of pressure ulcers in the United States is a 
staggering expense ranging from $2.2 to $3.6 billion a year (Calianno 2007a; Calianno, 2007b) 
with the mean cost of $43,180 per hospital stay (Department of Health and Human Services, 
2008).  Effective October 1, 2008, The Centers for Medicare and Medicaid Services (CMS) no 
longer reimburse hospitals for treating Stage III or IV HAPU (Calianno 2007a; Calianno, 2007b; 
Berquist-Beringer et al. 2009).  With the devastating effects to patients and healthcare 
institutions, nursing is challenged with identifying innovative ways to prevent pressure ulcers 
from occurring.  In the critically ill population, early identification of patient characteristics and 
comorbid risk factors are needed to isolate those at high-risk, with implementation of evidence-
based preventive strategies to reduce incidence of pressure ulcer formation. An important recent 
preventive strategy includes the use of soft silicone-foam bordered dressings (Mepilex® Border 
Sacrum, Mölnlycke Health Care) with varied degrees of success (Brindle, 2010; Butcher & 
Thompson, 2010; Brindle & Wegelin, 2012; Chaiken, 2012; Walsh et al., 2012; Cubit et al., 
2013, Santamaria et al., 2013). The purpose of this study is to describe patient characteristics and 
variables associated with skin breakdown and HAPU development among a critically ill patient 
population to whom Mepilex® has been applied for the prevention of sacral pressure ulcer 
development.  We hypothesized that the application of the Mepilex® dressing to the sacrum 
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would reduce the incidence of HAPU formation in our ICU patient sample throughout the length 
of hospitalization.   
Background 
Pressure ulcers are wounds caused by constant pressure to underlying skin tissue (Reilly, 
Karakousis, Schrag, & Stawicki, 2007).  The breakdown of skin occurs from an insufficient 
blood supply, typically at bony prominences commonly the sacrum, elbows, knees, occiput, 
ischium, heels, and coccyx (Smeltzer, Bare, Hinkle, & Cheever, 2008; Brindle & Wegelin, 
2012).  The prolonged and unrelieved pressure on skin causes an occlusion of blood flow, 
ischemia, and ultimately cell death (Salcido, Popescu, & Ahn, 2007). The skin is the largest 
organ of the body and its integrity is dependent upon the function of all other organ systems for 
nutrition, circulation, and immune function.  Even with multifocal preventive interventions, the 
burden of disease in the acutely hospitalized patient can overwhelm the skin and lead to HAPU 
formation (Armstrong et al., 2008). The severely debilitated patient with multisystem failure is at 
greatest risk, and part of our role as bedside clinicians is identifying the problem early and 
intervening to reverse pressure related skin changes (Calianno, 2007a).  
Critically ill patients are at high risk for developing HAPU due to intrinsic and extrinsic 
factors.  Intrinsic factors include impaired mobility and motor dysfunction, muscular atrophy, 
impaired sensory perception or cognition, decreased tissue perfusion, poor nutritional status, and 
altered mental status or consciousness. Extrinsic factors include the exposure of body surfaces to 
pressure, friction, shear, and moisture (Brindle & Wegelin, 2012).  In addition to these factors, 
critically ill patients may have further comorbid chronic and acute medical diagnoses that put 
them at the highest risk of pressure ulcer development (Reilly et al., 2007; Cox 2011). 
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Identification of patients at risk for pressure ulcer development is important for 
prevention initiatives. Several validated assessment tools designed to identify patients at risk for 
pressure ulcers, (e.g., the Braden Scale, Norton Scale, Waterlow Scale) have been developed and 
tested (Norton, 1962; Waterlow, 1987; Braden & Bergstrom, 1989). In a literature review, 
McGough, (1999) reported over 40 different pressure ulcer prevention tools.  It was concluded 
that none of these tools were consistently reliable for all clinical situations, as different patient 
groups have different clinical needs and pressure ulcer prevention tools should be used in the 
appropriate clinical setting.  One of the most widely accepted pressure ulcer risk assessment 
tools, which has shown to have the best reliability and validity indicators in various healthcare 
settings, is the Braden Scale, which produces a pressure ulcer risk score based on known risk 
factors of mobility, altered mental status/consciousness, moisture, and nutrition (Braden & 
Bergstrom, 1989; Braden Scale, n.d.).  The Braden Scale addresses six categories for predicting a 
pressure score risk including: sensory perception, moisture, activity, mobility, nutrition, and 
friction and shear (Bergstrom et al., 1987; Braden & Bergstrom, 1989).  A Braden score of 12 or 
less indicates the greatest risk, a score of 13-18 is low to moderate risk, and greater than 18 
indicates the lowest risk. Patient characteristics and severity of illness in the ICU population puts 
a majority of patients in Braden’s high-risk, if fact Brindle (2010) stated nearly 100% of ICU 
patients have a Braden Score of 18 or less, indicating HAPU risk.  Several studies have 
suggested that the six Braden categories are not significantly predictive for pressure ulcer 
development in the critically ill population, indicating a possible limitation of the Braden Scale 
when applied to ICU patients. These studies have shown that the categories of mobility and 
friction/shear (Cox, 2011), moisture and mobility (Bours et al., 2001), sensory perception 
(Carlson et al., 1999), and friction and shear (Tescher et al., 2012) are significant predictors 
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within ICU populations. Although the Braden Scale can predict increased risk for skin 
breakdown in the ICU patient, the sole reliance on this tool may limit the use of additional 
preventive interventions for the high-risk individuals among ICU nurses (Brindle, 2010).  
In addition to the Braden Score, numerous scoring systems have been developed to 
determine acuity or severity of illness scores for patients admitted to the hospital and ICU. Two 
examples are the Acute Physiology and Chronic Health Evaluation (APACHE) score or the 
Sequential Organ Failure Assessment (SOFA) score.  These tools can be used on acutely ill 
patients to determine acuity or severity of illness, and predict mortality and morbidity.  Another 
benefit of using these scoring tools in research trials is the advantage of assessing patients in 
trials with restrictive eligibility criteria, which eliminates patients with comorbid disease. In 
other words, restrictive criteria increase the certainty that any observed difference is attributable 
to the disease or treatment, and not confounded by comorbid disease (Charlson et al., 1986).  
Eliminating patients with comorbid conditions from trials increases the efficiency of the trial, but 
does so at a cost of limited generalizability beyond the population studied and possible poor 
participant recruitment and participant attrition (Charlson et al., 1986).  An alternative approach 
for research trials is to classify patients with comorbid diseases and their risk for mortality during 
participation in the study.  The Charlson Comorbidity Index (CCI) uses a weighted index of 
comorbidity comprised on various medical conditions and assigns a weighted risk (score 1, 2, 3 
or 6) for these diseases.  Charlson et al., (1986) found that the number and seriousness of 
comorbid diseases was a significant predictor of 1-year survival (p <0.0001) and at each 
increased level of weighted risk, there was a stepwise increase in the cumulative mortality 
attributable to the comorbidity index (p <0.0001) (Charlson et al., 1986).  CCI was determined to 
a valid, reliable method for estimating risk of death from comorbid disease for use in 
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longitudinal studies (Charlson et al., 1986).  The relevance with comorbidity exists with pressure 
ulcers, because it is known that comorbid disease is a major risk factor for developing pressure 
ulcers and affects the healing process for individuals suffering from pressure ulcers (Cox, 2011; 
NPUAP, 2013).  
A review of the literature identified a number of studies using a novel approach in 
preventing ulcers by using an absorbent soft, silicone self-adherent foam border dressing in the 
sacral area before pressure ulcers develop (Brindle, 2010: Butcher & Thompson 2010; Brindle & 
Wegelin 2012; Chaiken, 2012; Walsh et al., 2012; Cubit et al., 2013; Santamaria et al., 2013). 
Brindle (2010) performed a research study utilizing absorbent soft silicone self-adherent 
dressings in a surgical-trauma ICU.  Of the 41 identified high-risk patients that received the 
preventive sacral dressing, there was a zero percent pressure ulcer incidence in the treatment 
group.  A subsequent study comparing a preventative Mepilex® group (n=50) to a standard care 
group (n=35), resulted in a reduced pressure ulcer incidence in the treatment group (Brindle & 
Wegelin, 2012). Chaiken (2012) and Walsh et al. (2012) reported reduced pressure ulcer 
incidence when the Mepilex® dressing was applied to patients during quality improvement 
initiatives.  Similarly a study of early preventive intervention to utilize the sacral Mepilex® 
amongst individuals in the emergency department supports the findings of reduced HAPU 
incidence (Cubit, 2012). More recently, a randomized control trial in Australia demonstrated 
statistically and clinically relevant reduction of heel and sacral pressure incidence by 10% 
between the Mepilex® intervention and control groups (Santamaria et al., 2012).  
Bethesda North Hospital, part of the TriHealth organization, is a Level III care facility.  
Specifically, the Medical Surgical Intensive Care Unit (MSICU) provided the setting for this 
study.  This mixed population ICU consists of 22 beds with an additional 10 beds for the 
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Cardiovascular ICU.  The cardiovascular ICU population was excluded from this study. At 
Bethesda North Hospital, pressure ulcer prevention standards of care are based on an 
interdisciplinary approach including identification of pressure ulcer risk through Braden Scoring 
(Bergstrom et al., 1987), nursing interventions such as turning patients every two hours, use of 
skin care products, as well as specialty pressure redistribution devices and beds.  A collaborative 
effort utilized evidence-based practices as a quality improvement process to implement the use 
of the Mepilex® dressing as an additional preventive intervention to reduce HAPU incidence and 
improve patient outcomes. This study examines the outcomes of the use of the Mepilex® 
dressing on HAPU formation and skin breakdown as well as patient characteristics and other 
variables associated with skin breakdown among ICU patients.  
Methods 
Design, Sample, & Setting 
This study is part of longitudinal cohort study investigating the effect of a prophylactic 
Mepilex® dressing on pressure ulcer incidence. TriHealth’s Institutional Review Board approved 
the study.  Informed consent was obtained from each participant by the Primary Investigator and 
one enrollment nurse upon patient admission to the MSICU.  Patients are admitted to the MSICU 
from various settings, including direct admission from external facilities or transfer from other 
departments within the hospital.  The reason for admission to the MSICU was based upon the 
patient’s clinical severity or acuity of illness requiring intensive monitoring or specialized 
therapy.  All patients admitted into the MSICU at Bethesda North Hospital from March 1, 2011 
through May 31, 2011 were evaluated for inclusion and exclusion criteria. A checklist protocol 
enumerated criteria that would determine if the participant should have a Mepilex® dressing 
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applied. The checklist was derived from Brindle’s patient selection tool (Brindle, 2010; Brindle 
& Wegelin, 2012) which included criteria for automatic application of the Mepilex® dressing. 
These included surgical procedures lasting greater than 4 hours, cumulative surgeries lasting 8 
hours or more per current admission, cardiac arrest, rapid response, vasopressor use, body mass 
index (BMI) >40 or <18, mechanical ventilation, quadriplegia or spinal cord injury, drive line 
use such as ventricular assist devices or Intra Aortic Balloon Pump (IABP), Rotoprone, 
Continuous Renal Replacement Therapy (CRRT), continuous and bi-level positive airway 
pressure (CPAP/BIPAP), Braden score <13, and past history of pressure ulcers.  In addition to 
the automatic criteria, a list of secondary factors included weeping edema/anasarca, traction, age 
>65 years old, a preexisting diabetes mellitus diagnosis, bed rest, liver failure, malnutrition 
defined as prealbumin < 20 mg/dL, albumin <2.5 g/dL, nothing by mouth for 3 or more days, 
sedation/paralytic use, restraint use, or fecal/urinary incontinence not controlled by a indwelling 
catheter or fecal management device. 
After enrollment into the study, entire body skin assessments for any noted changes in 
skin integrity occurred every three days throughout the entire length of hospitalization.  
Concurrently during this assessment, the Mepilex® was removed and the sacral coccygeal skin 
was assessed, and the research team replaced the Mepilex® dressing. The research team utilized 
data collection forms to record assessment findings, indicated the inclusion criteria applicable to 
the patient on each assessment day, and calculated the Braden Scale pressure ulcer risk 
assessment score. 
Prior to the start of the study, all units within Bethesda North Hospital were notified of 
this study and education on the daily care procedures for the application, monitoring, and 
documentation of the Mepilex® dressing was provided.  In-service education was delivered on 
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Braden Scale calculation and TriHealth’s standards for preventive care measures for skin 
breakdown.  During the course of the study, the Primary Investigator was available to provide 
support to the unit nurse as well as address participant needs.  
Measures 
Independent variables. 
Several independent variables were measured, including the maximum number of criteria 
for applying the Mepilex® dressing during the patient’s length of hospitalization, Braden Scale 
score, primary diagnoses, BMI, demographic variables, length of hospitalization in days, and the 
number of days spent in the MSICU.  To measure the burden of comorbid disease, Charlson’s 
Comorbidity Index  (Charlson et al., 1987) calculated a weighted score based on the number of 
comorbid diseases.  Charlson’s Comorbidity Index was used was used to determine the level of 
comorbidity that existed among participants.  With statistical manipulation, comorbidity can be 
“leveled” so the influence of comorbidity can be equal among all participants, thus suggesting 
results are more of an influence of the intervention being studied.  Additionally, higher CCI 
levels are indicative of a greater comorbidity and illness among participants, suggesting a greater 
exposure to patient specific characteristics and hospital-based interventions to manage a higher 
level of illness, thus a potentially higher risk of skin breakdown. 
Independent variables also included the criteria used to assess whether patients require 
Mepilex® dressing application.  These criteria are surgical procedures lasting greater than 4 
hours, cumulative surgeries lasting 8 hours or more per current admission, cardiac arrest, rapid 
response, vasopressor use, body mass index (BMI) >40 or <18, mechanical ventilation, 
quadriplegia or spinal cord injury, drive line use such as ventricular assist devices or Intra Aortic 
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Balloon Pump (IABP), Rotoprone, Continuous Renal Replacement Therapy (CRRT), continuous 
and bi-level positive airway pressure (CPAP/BIPAP), Braden score <13, and past history of 
pressure ulcers.  In addition to the automatic criteria, a list of secondary factors include weeping 
edema/anasarca, traction, age >65 years old, a preexisting diabetes mellitus diagnosis, bed rest, 
liver failure, malnutrition defined as prealbumin < 20 mg/dL, albumin <2.5 g/dL, nothing by 
mouth for 3 days or more, sedation/paralytic use, restraint use, or fecal/urinary incontinence not 
controlled by a indwelling catheter or fecal management device. 
Dependent variables. 
The primary dependent variable was measured by the presence of skin changes noted on 
the sacral area during hospitalization, along with a secondary dependent variable of any skin 
breakdown noted on all areas of skin.  The research team completed skin assessments and 
documented any changes in skin integrity, and staged the breakdown according to the National 
Pressure Ulcer Advisory Panel guidelines (NPUAP, 2007) guidelines.  A skin assessment tool 
was designed specifically for this study, based on one from a similar study measuring covariates 
of pressure ulcer risk among patients with Mepilex® dressings (Brindle, 2010; Brindle & 
Wegelin, 2012).  All research personnel were simultaneously trained on how to complete the 
assessment form by the Primary Investigator, and were able to demonstrate correct 
documentation on the assessment tool. It should be noted that no studies have tested the 
reliability or validity of this assessment tool. Noted skin changes that did not meet criteria of the 
NPUAP guidelines but may have been suggestive of early skin impairment, such as pink, 
reddened, or blanchable skin, were documented by description.  For analysis, the primary and 
secondary dependent variables were dichotomized into having skin breakdown, coded as “1” and 
not having skin breakdown coded as “0.” 
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Data Analysis 
Of the 50 participants enrolled in the study, two withdrew and data from one patient was 
lost during the study, thus the analysis was based on data from 47 individuals.  Descriptive 
analysis was completed for the sample characteristics using means with standard deviation for 
continuous variables and frequencies for categorical variables.  Descriptive statistics included 
frequency of skin breakdown on any body part, including the sacrum.  In addition to the 
frequency of skin integrity changes, a description of what type of breakdown was included, 
based on NPUAP guidelines.  Independent sample t-tests [with Levene’s test for equality of 
variance] were used to examine the mean differences in skin break down and continuous study 
variables including age, length of stay for entire hospitalization, the number of days in the ICU, 
Charlson’s comorbidity index, and the maximum number of application criteria. Fisher’s exact 
tests were further used to examine differences in skin break down with categorical variables. 
Univariate logistic regression analyses examined the association between all study variables and 
skin breakdown. Since no participant with skin breakdown had a Braden Score greater than 12, 
the Braden Score was used as a continuous variable for the logistic regression analysis.  For all 
analyses an alpha level p=<0.05, and all analyses will be performed using IBM statistics version 
20 (IBM Corp., Armonk, NY, USA).   
Results 
Sample Description 
Table 1 provides a description of the sample.  The majority of the sample was female 
(57.4%), with mean age of 71.1 (± 11.9) years, Caucasian (91.5%), and had private health 
insurance (53.2%). The majority of the sample (40%) was obese (i.e., BMI > 30).  The maximum 
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number of enrollment criteria during the individual’s length of hospitalization showed a mean of 
5.9 (± 2.6) criteria. The mean length of hospitalization for the sample was 10.7 (± 7.8) days with 
5.0 (± 3.2) days spent in the MSICU.  The mean Braden Score on admission was 11.7 (± 2.0), 
with 87.2% of the sample having a Braden Score ≤ 12. The mean Charlson comorbidity index 
score was 3.5 (± 2.4) suggestive that the overall sample had existing comorbid disease burden, 
which is suggestive that higher comorbidity may increase risk for pressure ulcers (Cox, 2011; 
NPUAP, 2013). In comparison to individuals without skin breakdown, individuals with any skin 
breakdown had longer lengths of stay, more days spent in the MSICU, lower Braden Scores, 
higher Charlson comorbidity index, and increased number of qualifying enrollment criteria. 
Individuals with respiratory and cardiac admitting diagnoses were more likely to have skin 
breakdown as compared to those with surgical or other admitting diagnoses (p = .013).  
Furthermore, individuals with a lower Braden Scale score on admission had higher rates of skin 
breakdown (p = .031).    
HAPU Occurrence and Skin Breakdown 
Of the 47 participants, two (4.3%) developed sacral HAPU.  The first participant 
developed a Stage II pressure ulcer on day seven of the hospital stay, which resolved by time of 
discharge. The second participant developed a Stage II pressure ulcer on day 17 that was present 
at the day of discharge.  Twenty individuals developed skin breakdown, which was defined as a 
staged pressure ulcer defined by NPUAP or signs of early skin breakdown as red, pink, 
blanchable skin.  Among the 20 individuals, there were 5 (25%) Stage-I wounds, 4 (20%) deep 
tissue injury (DTI), 3 (15%) Stage II, and 12 (60%) indicative of early skin breakdown.  These 
wounds were noted on elbows, ears, hip, buttocks or gluteal fold, lip, toes, and ankles. 
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Association Between Application Criteria for Mepilex® and Sacral Skin Breakdown or any 
Skin Breakdown 
Figure 1 illustrates the association between sacral skin breakdown or any skin breakdown 
along with salient criteria used at enrollment for the application of the Mepilex® dressing.  
Sacral skin breakdown was associated with the use of restraints (p = .052). Any skin breakdown 
was significantly associated with restraint use (p = .000), sedation/paralytic administration (p = 
.001), CRRT (p = .038), and mechanical ventilation greater than 12 hours (p = .021).   
Other Study Variables Associated with Any Skin Breakdown 
Eleven potential predictors of any skin breakdown were examined (Table 2).  As 
compared to ‘other’ diagnoses, a respiratory (OR- 19.5, p= .003) or cardiac (OR-6.50, p= .058) 
primary diagnoses were strong predictors for skin breakdown.  Moreover as compared to those 
with 2-4 application criteria, those with 5-7 (OR= 7.11, p= .018) and those with 8-12 (OR= 9.60, 
p= .007) were more likely to have skin breakdown.  While many of the variables did not 
demonstrate statistical significance (possibly due to low power), those that may indicate clinical 
relevance include individuals who were male, 66 years of age or older, and with a BMI greater 
than 25, with a greater likelihood to develop skin breakdown compared to their referents.  
Discussion 
The purpose of this study was to examine factors associated with HAPU and skin 
breakdown among ICU patients with a preventative sacral Mepilex® dressing.  Our findings 
suggest that several characteristics contribute to skin breakdown among patients in an intensive 
care unit including primary admitting diagnoses related to respiratory or cardiac medical 
conditions, ventilator use greater than 12 hours, use of sedation/paralytics and restraints, CRRT, 
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and Braden scores ≤ 12. These risk factors may be important in understanding the risk factors 
among ICU patients for skin breakdown leading to HAPU’s 
First, our study indicated an association between mechanical ventilator use greater than 
12 hours with sacral or any skin breakdown (p = .021), and individuals with a respiratory 
diagnosis on admission being predictive of HAPU formation (OR- 19.5, p= .003).  Studies have 
found that pressure ulcer development is related to respiratory illnesses, respiratory failure, and 
mechanical ventilation within the ICU and other settings (Reilly et al., 2007; Nijs et al., 2008; 
Senturan et al., 2009). Individuals who receive ventilation are typically sedated, immobilized 
from restraints, demonstrate high-risk Braden Scores (Carlson, 1999), have direct pressure 
exerted on the sacrococcygeal region from elevation of the head of bed, and have frequent 
friction and shearing forces from sliding increasing risk of damage to the skin (Santamaria et al., 
2013). This finding from our study suggest the need for a nursing protocol or interventions that 
increase the monitoring and assessment of skin for breakdown among individuals with a 
respiratory illness diagnosis and/or who are on mechanical ventilation while in the ICU setting. 
Second our findings support a cardiac primary diagnosis on admission (OR-6.50, p= 
.058) was a strong predictor for skin breakdown.  Our findings corroborate the findings of other 
studies, which have found that cardiovascular disease, hemodynamic instability, and vasopressor 
administration are significant factors associated with pressure ulcer formation (Carlson, 1999; 
Nijs et al., 2008; Cox, 2011; Tschannen et al., 2012). This hemodynamic instability can 
compromise tissue perfusion and may subsequently predispose the skin to ischemia that 
increases risk of skin breakdown. Hence, critically ill individuals with cardiac disease or 
hemodynamic instability and on vasopressors should also be monitored and assessed more 
frequently to reduce subsequent HAPU within the ICU setting. 
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Third, we found that CRRT therapy was associated with increased risk for skin 
breakdown (p = .038).  Limited studies have analyzed CRRT with pressure ulcer formation.  It is 
suggested that the association between CRRT and skin breakdown may be a result of the 
immobility caused by the dialysis intervention itself (Nijs et al., 2008). Future studies may 
examine the underlying mechanisms that determine the association between CRRT and pressure 
ulcer formation to develop adequate prevention strategies. 
Finally, in our study 87.2% had a Braden Score ≤ 12 with a mean Braden Score of 11.7.  
The calculated Braden scores at admission were significantly associated with skin breakdown (p 
= .031).  Studies have shown varied outcomes to total Braden Score and the reliability and 
validity of the individual six subscales as being predictive or only partially predictive of pressure 
ulcer risk (Bours et al., 2001; Carlson et al., 1999; Cox, 2011; Iranmanesh et al., 2012; Tescher et 
al., 2012).  Although our study indicates a relationship between the total Braden score and skin 
breakdown, further analyses would be needed to delineate if the six Braden subscales 
independently had a significant association for changes in skin integrity. However, such analyses 
are beyond the scope of the present study. Future studies with adequate sample sizes should 
examine the relationship between Braden Scale subscales and skin integrity. 
Limitations 
A small sample size (n=47) produced a homogenous sample with minimal 
generalizability outside of the ICU populations. Moreover there are other factors that may have 
affected pressure ulcer development that were not measured among patients such as smoking 
(Suriadi et al., 2007). In addition, the type of bed or mattress on which patients occupied was not 
considered as a variable in the study, due to the transition of patient care through the hospital and 
the variance of type of bed and mattress the patient occupied. Changes in the type of bed or 
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mattresses to which participants were assigned may have influenced pressure ulcer development. 
We also recognize the influence of staff education on the Mepilex® dressing prior to the start of 
this study, which may have influenced the results. Moreover, patient participation in this study 
and additional skin assessments and visits by the investigation team may have influenced nurses 
to engage in preventative skin measures more frequently than required.  We also recognize the 
limitation of our assessment tool, which was designed for this study without testing of validity or 
inter-rater reliability. Future research would benefit from a larger sample size with power 
analysis and participant, as well as use of an assessment tool with demonstrated validity. 
Conclusions 
As healthcare requirements become more stringent and reimbursement reliant upon 
quality patient outcomes, understanding additional factors that predispose patients to HAPU can 
allow for earlier identification in order to initiate preventive interventions.  ICU patients, many 
of whom are deemed high risk for HAPU, identification of individuals based on medical 
interventions and therapy such as ventilator use, sedation/paralytics administration, restraint 
application, CRRT, respiratory or cardiac medical diagnoses, and Braden Scale scores, may be 
considered for additional criteria for a pressure ulcer risk assessment tool.  The results of our 
study suggest that healthcare providers assess for patient characteristics and hospital-based 
interventions and therapies as additional variables for pressure ulcer risk.   Early and improved 
identification of such risk factors can lead to prevention strategies, such as use of prophylactic 
Mepilex® dressing use.  While this study did not compare incidence or prevalence rates found in 
this study to a comparison, we believe that among our population a notable difference in HAPU 
incidence was found between participants with “any skin breakdown” (n=20) and “sacral skin 
breakdown” (n=2). We suggest that along with an ICU specific assessment tool, there is clinical 
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relevance for the use of prophylactic silicone foam dressings.  Mepilex® dressing may be an 
easy solution to a significant problem with clinical practicality to potentially reduce new cases of 
iatrogenic pressure ulcers.  While few studies statistically show the benefits of Mepilex® and 
reduce HAPU incidence, the clinical practicality exists to use Mepilex® as an adjunctive therapy 
to nursing standards of care.  Hence it is recommended to incorporate a patient- and intervention-
specific assessment tool, and utilize evidence based prevention strategies (such as the use of the 
Mepilex® dressing) as part of routine practice to lower HAPU incidence and enhance patient 
outcomes within the ICU setting. 
Relevance to Clinical Practice 
Assessment of the identified risk factors for skin breakdown can be applied to traditional 
pressure ulcer risk assessment scores to improve early identification of critically ill individuals at 
risk for pressure ulcer formation.  Individuals with these identified variables may benefit from 
prophylactic silicone dressings as a pressure ulcer prevention strategy to reduce HAPU 
incidence.  With insurance reimbursement more reliant upon patient outcomes, hospitals must 
implement new screening tools and nursing interventions to reduce hospital-acquired conditions.  
Hospitals that modify existing standards of care to include additional risk assessments (such as 
the tool used in this study) and incorporate Mepilex® dressings as an adjunctive therapy may 
benefit from reduce HAPU incidence.  
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Table 1: Sample Characteristics 
a. Any skin breakdown includes pressure related changes based on the NPUAP staging guidelines, deep tissue injury (DTI), unstageable wounds, 
incontinence associated skin changes, and signs of early pressure related changes of red/pink blanchable skin on all areas of the body. 
b. The primary diagnosis on admission were categorized into respiratory (including individuals with chronic obstructive pulmonary disease, 
pneumonia, respiratory failure, pleural effusion), cardiac (including individuals with myocardial infarction, arrhythmias, hyper/hypotension, 
vascular disorders, and stroke), surgery (including individuals with neurosurgery, exploratory laparotomy, nephrectomy, orthopedic surgery), and 
other (metabolic disorders, GI bleed, neurologic disorders, and sepsis/septic shock) 
c. Braden scores range from 6-23, with lower scores indicating greater risk for pressure ulcer development 
 Total 
(N = 47) 
No Skin 
breakdown 
(n = 27) 
Any skin 
breakdowna 
(n = 20)  
Difference 
 n % n % n % p 
Gender       .551 
Male 20 42.6 10 37.0 10 50.0  
Female 27 57.4 17 63.0 10 50.0  
Age        
<65 12 25.5 9 33.3 3 15.0 .191 
66> 35 74.5 18 66.7 17 85.0  
Ethno/Cultural       .836 
Caucasian 43 91.5 25 92.6 18 90.0  
African American 2 4.3 1 50.0 1 5.0  
Hispanic/Latin American 1 2.1 0 0 1 5.0  
Asian/Pacific Islander 1 2.1 1 3.7 0 0  
Insurance Provider        .328 
Medicare 20 42.6 12 44.4 8 40.0  
Private  25 53.2 15 55.6 10 50.0  
No insurance/ Self-pay 2 4.3 0 0 2 10.0  
Primary Diagnoses on admissionb       .013 
Respiratory 12 25.5 3 11.1 9 45.0  
Cardiac 10 21.3 5 18.5 5 25.0  
Surgical 10 21.3 6 22.2 4 20.0  
Other 15 31.9 13 48.1 2 10.0  
Braden score categoriesc       .031 
6-12 41 87.2 21 77.8 20 100  
13-18 6 12.8 6 22.2 0 0  
Body Mass Index       .546 
<18.5 (Underweight) 3 6.4 3 11.1 0 0  
18.6-24.9 (Normal) 12 25.5 7 25.9 5 25.0  
25-29.9 (Overweight) 13 27.7 7 25.9 6 30.0  
> 30.0 (Obese) 19 40.4 10 37.0 9 45.0  
 Mean SD Mean SD Mean SD p 
Length of Hospital Stay 10.7 7.8 10.1 8.3 11.5 7.1 .551 
Number of days in the MSICU 5.0 3.2 4.3 2.9 5.9 3.3 .104 
Braden Score 11.7 2.0 12.0 2.4 11.4 1.4 .321 
Charlson co-morbidity index scores 3.5 2.4 3.2 2.3 3.8 2.6 .421 
Maximum number of Mepilex® application criteria 5.9 2.6 5.0 2.3 7.2 2.4 .801 
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Table 2. Univariate logistic regression analyses to determine factors associated with any skin 
breakdowna 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a. Any skin breakdown includes pressure related changes based on the NPUAP staging guidelines, deep tissue injury (DTI), unstageable wounds, 
incontinence associated skin changes, and signs of early pressure related changes of red/pink blanchable skin on all areas of the body. 
b. The Medicare category includes two individuals who had no insurance or self-pay. 
c. The primary diagnosis on admission were categorized into respiratory (including individuals with chronic obstructive pulmonary disease, 
pneumonia, respiratory failure, pleural effusion), cardiac (including individuals with myocardial infarction, arrhythmias, hyper/hypotension, 
vascular disorders, and stroke), surgery (including individuals with neurosurgery, exploratory laparotomy, nephrectomy, orthopedic surgery), and 
other (metabolic disorders, GI bleed, neurologic disorders, sepsis/septic shock) 
d. Body Mass Index includes three individuals who were underweight and were combined with the normal weight category for analysis 
 Any Skin Breakdown 
(Univariate) 
 B [s.e] OR [95% CI] 
Gender   
Male (referent) 1.00 - 
Female -.53 [0.60] 0.59 [0.18-1.90] 
Age   
<65 (referent) 1.00 - 
66> 1.04 (0.75) 2.83 [0.66-12.26] 
Ethno/Cultural   
Caucasian -.33 [1.05] 0.72 [0.09-5.60] 
Other (referent) 1.00 - 
Insurance Provider    
Medicareb -.18 [0.60] 0.83 [0.26-2.69] 
Private  (referent) 1.00 - 
Primary diagnoses on admissionc   
Respiratory  2.97 [1.01] 19.50 [2.69-141.35] 
Cardiac 1.87 [0.99] 6.50 [0.94-45.11] 
Surgical 1.47 [1.00] 4.33 [0.61-30.57] 
Other (referent) 1.00 - 
Braden score   
Body Mass Indexd   
<18.5-24.9 (Underweight/Normal) (referent) 1.00 - 
25-29.9 (Overweight) .54 [0.78] 1.71 [0.37-7.92] 
> 30.0 (Obese) .59 [0.72] 1.80 [0.44-1.31] 
   
Maximum number of Mepilex® criteria during 
length of stay 
  
2-4 (referent) 1.00 - 
5-7 1.96 [0.83] 7.11 [1.40-36.12] 
8-12 2.26 [0.84] 9.60 [1.85-49.88] 
Length of hospital stay (Days) .02 [.04] 1.02 [.95-1.10] 
Number of days in the MSICU .16 [.10] 1.17 [.96-1.43] 
Charlson comorbidity index scores .10 [.13] 1.11 [.87-1.42] 
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Figure 1: Association between criteria for Mepilex® application and observed sacral or any skin 
breakdown 
 
 
WOCN= Wound Ostomy and Continence Nursing, NPO= Nothing by mouth, CPAP/BiPAP= Continuous Positive 
Airway Pressure/Bi-level Positive Airway pressure, CRRT= Continuous Renal Replacement Therapy, BMI= Body 
Mass Index 
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Abstract 
Objective:  To implement a Hospital-Acquired Pressure Ulcers (HAPU) prevention program 
utilizing an assessment tool to identify patients at risk, and intervene with a sacral Mepilex® 
dressing. Our aims are to determine if a change in nursing knowledge and change in nursing 
behavior after implementing our program. 
Background:  HAPUs are a significant problem in patient care and healthcare organizations 
must implement prevention protocols to reduce HAPU prevalence.  Guidelines for implementing 
HAPU prevention programs suggest use of a validate risk assessment tool and initiating 
preventive interventions.  One intervention found in the literature is the adjunctive use of 
prophylactic Mepilex® dressings to sacral skin.  
Design:  Descriptive study with a prospective one-group pre and post-test design, followed by a 
retrospective medical record review. 
Methods:  A HAPU education was disseminated to TriHealth nurses who voluntarily 
participated in a 15-question test before and after the HAPU educational didactic.  A paired t-test 
was performed to determine a difference in mean pre/post-test scores.  After completion of the 
educational didactic, units with 65% completion were included in a medical record review to 
determine adherence to nursing clinical behaviors relating to the new policy.  
Results:  1,182 nurses completed the pre-test and 1,514 completed the post-test.  Paired t-test 
analysis determined a difference in mean scores before and after our educational intervention, 
indicating change in nursing knowledge.  65 medical records were reviewed from 5 units at 
TriHealth.  The mean percent completion of required documentation was 62.2%, and an analysis 
of variance determined a difference in mean percent completion scores between hospitals, but 
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not unit location.  Nurses correctly identified at-risk patients in 50.8% of medical records and 
used a prophylactic Mepilex® dressing; however 16.9% of at-risk patients were missed.  The 
most identified Mepilex® application criteria included age >65 years, mechanical ventilator use, 
surgical procedures lasting ≥4 hours, and Braden Scale scores <13. 
Conclusion:  A change in nursing knowledge was evident after our educational didactic, 
however, our medical record review indicates a failure to consistently follow the HAPU protocol 
to identify, intervene, and maintain pressure ulcer prevention practices for patients at-risk.   
Relevance to Clinical Practice:  This HAPU prevention protocol may be successful at changing 
nursing knowledge, but had variable impact on changing nursing behaviors.  Additional program 
evaluation is needed to identify areas to support our nurses for long-term sustainability. 
Keywords:  HAPU, pressure ulcer, implementation, adherence, Mepilex®, silicone dressing 
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Implementing a Hospital-Acquired Pressure Ulcer Prevention Protocol with a Sacral Mepilex® 
Dressing and Evaluation of Nursing Protocol Adherence  
Introduction 
Pressure ulcers are wounds caused by constant pressure to underlying skin tissue 
(Cuddigan, Berlowitz, & Ayello, 2001).  The breakdown of skin occurs from an insufficient 
blood supply at bony prominences commonly the sacrum, coccyx, ischium, occiput, knees, and 
ankles (Smeltzer, Bare, Hinkle, & Cheever 2008; Brindle & Wegelin, 2012).  The prolonged and 
unrelieved pressure on skin causes an occlusion of blood flow, ischemia, and ultimately cell 
death (Salcido, Popescu, & Ahn, 2007).  Acutely ill patients are at greatest risk for pressure 
ulcers from intrinsic and extrinsic factors.  Intrinsic factors include impaired mobility and motor 
dysfunction, muscular atrophy, impaired sensory perception or cognition, decreased tissue 
perfusion, poor nutrition, and altered mental status or consciousness.  Extrinsic factors include 
the exposure of body surfaces to pressure, friction, shear, and moisture (Allman, Gosnell, 
Bergstrom, & Cuddigan, 1993).  In addition to these factors, acutely ill hospitalized patients have 
co-morbid chronic and acute medical diagnoses that put them at the highest risk for pressure 
ulcer development (Reilly et al., 2007; Cox, 2011). Even with preventive interventions, the 
burden of disease and comorbidity can overwhelm the skin allowing for the formation of 
pressure ulcers (Armstrong, Ayello, et al., 2008).  Iatrogenic pressure ulcer development that 
occurs as a result of healthcare involvement is termed Hospital-Acquired Pressure Ulcer or 
HAPU. 
HAPUs are a significant problem in patient care and have deleterious implications for the 
patient and the healthcare system.  The development of pressure ulcers increased the length of 
hospital stay on average by 4 days (Calianno, 2007b).  Between 1999 and 2003 a 63% increase 
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in length of stay occurred in which pressure ulcers were a listed diagnosis in patient medical 
record (Calianno, 2007b).  Among patients with pressure ulcers, self-reports described an 
increase in pain and suffering (Pieper et al., 2009). HAPU complicates the healing process and 
increased the mortality likelihood for hospitalized patients, which were reported as the cause of 
death for 115,000 individuals between 1990 and 2001 (AHRQ, 2013; Brem et al., 2010).  
Estimates for prevalence range from 0.4% to 38% in acute care hospitals (AHRQ, 2013).  The 
estimated cost of pressure ulcers in the United States ranges from $2.2 to $3.6 billion a year 
(Calianno 2007a, 2007b), with a mean cost of $43,180 per hospitalization (Department of Health 
and Human Services (DHHS), 2008).   
Background 
The Centers for Medicare and Medicaid Services (CMS) with support from the National 
Quality Forum (NQF) determined a list of serious and costly iatrogenic healthcare errors called 
“Never Events” (Calianno, 2007; CMS, 2006).  “Never Events” are errors that cause serious 
injury or death to the patient resulting in increased costs to treat (Calianno, 2007).  Twenty-seven 
“Never Events” are listed with CMS and NQF with Goal No. 14: Pressure Ulcer Prevention.  
Goal No. 14: Pressure Ulcer Prevention, recommends for the use of a validated risk assessment 
tool to identify patients at risk for development of pressure ulcers, and an approach to prevent 
injury in high-risk patient populations (Calianno, 2007; NPUAP, 1992).  In addition to the new 
standards to reduce the incidence of HAPU, CMS no longer reimburses hospitals for treating 
acquired Stage III or IV HAPU (Berquist-Beringer et al, 2009; Calianno, 2007; CMS, 2006). 
The CMS “Never Event” payment provisions for HAPU reimbursement has resulted in 
healthcare providers to develop pressure ulcer prevention strategies and interventions for 
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professional advancement, quality patient care, and financial survival.  The suggested preventive 
strategies include: patient education, clinician training, developing communication and 
terminology materials, implementing protocols, and ensuring healthcare and patient provider 
adherence to standards of care and policies.  Healthcare literature identifies integrating the 
components of simplification and standardization of pressure ulcer interventions and 
documentation as ways to improve process of care (Armstrong et al, 2008; Sullivan & Schoelle, 
2013).  In addition to providing preventive strategies, clinicians must be able to identify patients 
deemed at risk of skin breakdown.  Numerous patient characteristics and hospital-based variables 
were associated with skin breakdown, however, the key implication derived from evidence-based 
literature suggest that understanding and identifying these high-risk factors is important for early 
detection (Bours et al., 2001; Nijs et al., 2008; Cox, 2011). 
Identification of patients at risk for HAPU development is an important prevention 
initiative.  Several validated assessment tools designed to identify patients at risk for pressure 
ulcers (e.g., the Braden Scale, Norton Scale, Waterlow Scale) have been developed and tested 
(Norton, 1962; Waterlow, 1987; Braden & Bergstrom, 1989). In a literature review, McGough, 
(1999) reported over 40 different pressure ulcer prevention assessment tools.  It was concluded 
that none of these tools were consistently reliable for all clinical situations, as different patient 
groups have different clinical needs, and pressure ulcer prevention tools should be used in the 
appropriate clinical setting.  One of the most widely accepted pressure ulcer risk assessment tool, 
which has shown to have the best reliability and validity indicators in various healthcare settings, 
is the Braden Scale, which produces a pressure ulcer risk score based on known risk factors 
(Braden & Bergstrom, 1989; Braden Scale, n.d.).  The Braden Scale addresses six risk factor 
categories for predicting HAPU risk including: sensory perception, moisture, activity, mobility, 
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nutrition, and friction and shear (Bergstrom et al., 1987; Braden & Bergstrom, 1989).  A Braden 
score of 12 or less indicates high risk, a score of 13-18 is low to moderate risk, and greater than 
18 indicates the lowest risk.  Several studies have suggested that individually the six Braden 
categories were not significantly predictive for pressure ulcer development in the acutely ill 
population, indicating a possible limitation of the Braden Scale when applied to this population. 
These studies have shown that the categories of mobility and friction/shear (Cox, 2011), 
moisture and mobility (Bours et al., 2001), sensory perception (Carlson et al., 1999), and friction 
and shear (Tescher et al., 2012) are significant predictors within acutely ill populations. Although 
the Braden Scale can predict increased risk for skin breakdown in the acutely ill patient, the sole 
reliance on this tool may limit the use of additional assessment and preventive interventions for 
the high-risk individuals (Brindle, 2010).  Another limitation of pressure ulcer risk assessment 
tools is the variability of knowledge and competence from nursing providers in the use of these 
tools.  Surveys of nursing competence on pressure ulcers demonstrate lack of confidence on 
knowledge of pressure ulcer identification, staging, and prevention (Berquist-Beringer, et al., 
2009).   
As important as it is for early identification of patients at risk for HAPU, nursing 
standards of care and policy must direct care providers to initiate preventive strategies.  Well 
known and understood evidence-based practices suggest interventions such as turning patients 
frequently, use of positioning devices, application of products for moisture control, optimizing 
nutrition, and promoting mobility and activity, for example (NPAUP, 2013).  An adjunctive 
HAPU prevention strategy has emerged in the literature using prophylactic soft silicone foam-
bordered dressings (Mepilex® Border Sacrum, Mölnlycke Health Care) among high-risk 
individuals to reduce HAPU development (Brindle, 2010; Butcher & Thompson, 2010; Brindle 
	  
58	  
	  
& Wegelin, 2012; Chaiken, 2012; Walsh et al., 2012; Cubit et al., 2013; Santamaria et al., 2013). 
The Mepilex® dressing reduces friction and shearing, wicks moisture away from the skin, 
provides a foam protective core for pressure redistribution, and the patented silicone technology 
(Safetac®) permits atraumatic removal of the Mepilex® for skin assessment and dressing change 
(Mölnlycke Health Care, 2015). 
In a review of six studies, specifically evaluating the prophylactic use of Mepilex® 
dressings and its efficacy, HAPU rates were decreased among individuals to whom a preventive 
Mepilex® was applied.  Brindle (2010) used the silicone self-adherent dressings in a surgical-
trauma ICU; of the 41 high-risk patients who received the preventive sacral dressing, there were 
no HAPUs in the treatment group compared with a prevalence of 11.5% in the control group.  A 
subsequent study comparing a standard care group (n=35) to a preventive Mepilex® group 
(n=50) resulted in a reduced pressure ulcer incidence from 11% to 2%, respectively (Brindle & 
Wegelin, 2012). Clinically relevant studies from Walsh et al. (2012) reported a 5.5% difference 
in pressure ulcer rates in a quality improvement initiative using sacral Mepilex® dressings, and 
Chaiken (2012) reported a prevalence rate of 13.3% prior to the use of Mepilex® dressings, 
which was reduced to 1.3% after Mepilex® dressing use was implemented in their ICU.  
Similarly in a retrospective medical record review evaluating early preventive intervention 
utilizing the sacral Mepilex® among individuals admitted from the emergency department, 
findings demonstrated reduced HAPU incidence with a difference of 8.3% between the 
Mepilex® intervention group and the control group (Cubit et al., 2013). More recently, a 
randomized controlled trial in Australia showed statistically and clinically relevant reduction of 
heel and sacral pressure incidence by 10% (p = 0.001) between the Mepilex® intervention and 
control groups (Santamaria et al., 2013). Thus, prophylactic sacral Mepilex® application has 
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promising data to support HAPU reduction, and are suggestive to healthcare organizations to 
integrate protocols for the application of a prophylactic Mepilex® dressing as adjunctive therapy 
to current nursing standards of care for individuals at risk for skin breakdown.   
It is known that implementing preventive strategies will reduce HAPU from occurring, 
and the immediacy of implementing HAPU protocols is crucial to attaining quality improvement 
(Calianno, 2007b; Barker et al., 2013; Sullivan & Schoelles, 2013).  Guidelines for implementing 
pressure ulcer prevention within hospital organizations suggest 1) use of a validate pressure ulcer 
risk assessment and 2) use of pressure ulcer prevention interventions (Barker et al., 2013, 
Calianno, 2007b).  With the focus of implementing new HAPU prevention guidelines within our 
healthcare organization, our recommendations are twofold.  First, in the hospitalized population 
early identification of patient characteristics, comorbid risk factors, and hospital-based therapies 
are needed to isolate those at high-risk.  We are recommending, in addition to Braden Scale 
assessment, a nursing delivered patient-specific and therapy-specific assessment tool for all 
patients admitted to the hospital (Reilly, 2007; Cox 2011).  Second, with the evidence-based 
knowledge on HAPU prevention and supportive evidence from Mepilex® dressings as an 
adjunctive therapy, we are recommending patients deemed high-risk from our assessment tool 
have a prophylactic Mepilex® dressing applied and maintained during hospitalization (Brindle 
2010, Butcher & Thompson 2010, Brindle & Wegelin 2012, Chaiken 2012, Walsh et al., 2012, 
Cubit et al., 2013, Santamaria et al., 2013).  With these recommendations implementation of our 
evidence-based protocol for screening high-risk variables associated with skin breakdown may 
empower nurses to accurately identify patients for HAPU risk, intervene with nursing 
interventions, and be proactive in preventing HAPU development. 
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Methods 
Purpose 
Utilizing evidence-based recommendations, in conjunction with TriHealth’s Skin Care 
Committee, the Primary Investigator proposed changes to TriHealth’s Pressure Ulcers: 
Guidelines for Prevention and Treatment (see Appendix A).  The proposed changes include a 
protocol for the assessment of high-risk criteria among adult patients admitted to the hospital, 
and use of prophylactic Mepilex® sacral dressing for HAPU prevention.  This new protocol will 
require registered nurses to perform a skin assessment on all patients admitted to TriHealth for 
specific high-risk criteria, apply a Mepilex® dressing if applicable, and complete required 
maintenance and documentation of the dressing until the patient is discharged from the hospital.  
These changes are in addition to the current standards of care, and do not replace existing 
guidelines.  Guideline changes were reviewed and approved by TriHealth’s Skin Care 
Committee and Department of Wound Ostomy and Continence (WOCN), to ensure accuracy, 
expertise knowledge, and face validity on the proposed changes.  Additionally, all changes to 
this policy were reviewed and approved administratively by TriHealth’s Nursing Practice 
Council and Policy and Procedures Council prior to implementing this study. 
Our goal to implement new pressure ulcer prevention guidelines within TriHealth to 
standardize the identification of high-risk variables, requires education and training to the nurses 
responsible for the assessment and maintenance of these policy changes.  Effective use of the 
new protocol requires an increase in nursing knowledge about HAPU prevention and use of 
treatment strategies and clinical practice behaviors.  These include correct application of the 
Mepilex® dressing and consistent electronic medical record (EMR) documentation about skin 
assessments and strategies used for prevention and management.  Therefore, the purpose of this 
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study is to evaluate the knowledge difference before and after an education didactic pertaining to 
the policy changes and HAPU prevention with Mepilex® dressings and to evaluate the 
adherence to the change.  Our study had two specific aims, in Phase I, our purpose is to 
determine a change in nursing knowledge and in Phase II, our purpose is to determine a change 
in nursing clinical behavior through fidelity monitoring of nursing documentation adherence.   
Study Design and Setting  
 This descriptive study had a prospective design in Phase I with a didactic education 
provided to all registered nurses providing inpatient nursing care with a one-group pretest-
posttest design to determine whether mean scores on a HAPU knowledge assessment were 
significantly different.  Phase II was a retrospective medical record review to determine 
adherence to the new nursing standards of care and Mepilex® protocol via nursing 
documentation in the electronic medical record. TriHealth’s Nursing Education Council and 
Research Council approved both Phase I and II of this study.  Subsequently, the study underwent 
expedited review, including the waivers for informed consent, authorization, and documentation 
of informed consent, and was approved through the Institutional Review Board (IRB) (see 
Appendix B). 
The study occurred at Bethesda North Hospital, Good Samaritan Hospital, and Bethesda 
Butler Hospital in Cincinnati, Ohio.  These three hospitals collectively are part of the TriHealth 
organization, and provide a total of 1,028 inpatient beds.  TriHealth employs approximately 
3,000 nurses with roughly 2,000 nurses providing inpatient care to hospitalized patients.  Our 
population of interest for this study is the convenience sample of registered nurses at TriHealth 
that are considered to provide care on adult inpatient units and departments. 
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Procedure 
Phase I:  TriHealth uses an education platform called LEARN (Learning Effectiveness 
And Resource Network), a subsidiary of the Catholic Health Initiative HealthStream Learning 
Center, to disseminate education modules to TriHealth employees for voluntary continuing and 
mandatory education.  This platform was used to obtain the convenience sample (n=2,051) of 
nurses for our program, and to deliver the education and training for this study.  The Primary 
Investigator developed the education content to be delivered in the LEARN didactic education 
and created the 15 multiple-choice pretest/posttest questions (see Appendix C).  The expert 
knowledge and opinion from TriHealth’s Department of Wound Ostomy and Continence 
Nursing and Skin Care Committee was used to ensure face validity of the pressure ulcer content 
delivered in the LEARN education.  The content for the didactic education was submitted to 
TriHealth’s Corporate Education Department to be developed into the LEARN education 
module.  During the development phase of the LEARN module, the Primary Investigator 
maintained active participation to ensure accuracy of the content, reviewed, and approved the 
completed version prior to dissemination.  
On February 15, 2015 the LEARN didactic module was disseminated to 2,051 nurses at 
Bethesda North, Good Samaritan, and Bethesda Butler Hospitals.  Nurses were provided with a 
6-week due date to complete the education.  Each participant was notified via letter from the 
Primary Investigator (included in the module) of the nature of this study and their voluntary 
completion of the 15-question pre/post-test analysis.  Due to the changes in TriHealth’s standards 
of care and policy change, the educational content alone was considered mandatory for all 
inpatient nurses to complete.  The HAPU assessment test consisted of 15 multiple-choice 
questions.  The categorical breakdown includes seven questions pertaining to the Mepilex® 
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protocol and interventions, five questions pertaining to policy changes and standards of nursing 
care, two questions related to pressure ulcer staging, and one question in regards to Braden 
scoring.  Each TriHealth nurse has a unique and confidential username and password to access 
LEARN, and the freedom to complete the module at any preferred location.  There was no time 
limit to complete the pre/post-test evaluation or the education module once started, and nurses 
had the ability to stop the module and to return at a later time. 
Phase II:  After four weeks completion of the LEARN education didactic, inpatient units 
from Bethesda North, Good Samaritan, and Bethesda Butler Hospitals were assessed for percent 
completion of the HAPU prevention module.  Once units achieved 65% or greater completion of 
the LEARN didactic they were included for the medical record review in Phase II.  The LEARN 
database has the data reporting capability to indicate which units have achieved 65% or greater 
completion.  From this list, the Primary Investigator evenly divided 65 medical records for 
review.  The Primary Investigator utilized TriHealth’s EMR “TriHealth Connect” to obtain a 
master list of 65 randomly selected medical records paired with a unique identifier from the 
participating units.  All data extracted from the 65 medical records included de-identified 
medical data related to nursing documentation of the Mepilex® protocol.  The de-identified data 
for this portion of the study was collected and recorded on Sacral Silicone Foam Dressing 
Algorithm Fidelity Scale: Inpatient Chart Review Form (see Appendix D).  Later it was imported 
into an electronic spreadsheet that was used for data analysis. 
Rogers’ Theory of Diffusion and Innovation helps provide explanations why a new idea 
or technology is spread through organizational cultures (Rogers, 2003).  Rogers proposes 
different individuals will accept change at different rates and categorizes participants (percent of 
adopters) as early adopters (2.5%), innovators (13.5%), early majority (34%), late majority 
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(34%), and laggards (16%) (Rogers, 2003).  Rogers’ theory has been applied to many 
implementation studies as a systematic framework to how to acculturate new practices.  Critical 
mass effect, imbedded in Rogers’ Theory of Diffusion of Innovation, suggests that a specific 
number of adopters of a new innovation are required to produce a self-sustaining change or 
effect to achieve an end-result.  The concept of critical mass was used in this study as a proposed 
(necessary) percentage of 65% completion of the intervention in delivered in Phase 1, to produce 
the desired outcome of change in nursing clinical behaviors in Phase II.  Required critical mass 
percentages to achieve outcomes vary in the literature, with rates as low as 12% of adopters to 
achieve critical mass up to rates exceeding 30%, however, Rogers suggests about 10-20% 
adoption of the new innovation is needed to achieve critical mass (Rogers, 2003; Gladwell, 2002; 
Institute for Health Improvement, 2015).  In our study we selected a 65% rate of completion of 
the LEARN didactic, to capture a large enough sample whom completed the education.  With a 
higher completion rate, we hoped to reduce the possibility to selecting medical records for 
review being completed by a nurse who had not had the opportunity to complete the education.  
Within the 65% of nurses who completed the education, our desire was to capture nursing 
documentation in medical records completed by our early adopters (2.5%), innovators (13.5%), 
early majority (34%), and some of the late majority (34%).  Rogers’ Theory of Diffusion and 
Innovation, specifically critical mass, was applied to our medical record review in effort to 
reduce bias in our results. 
Data Analysis 
The LEARN educational didactic was disseminated to 2,051 inpatient nurses.  1,182 
nurses voluntarily participated in the pre-test, 1,514 participated post-test analysis, and 1,100 
submitted demographic data.  Descriptive analyses were completed for the sample characteristics 
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using frequencies for the nominal and ordinal categorical variables.  For the pre/post-test analysis 
we used descriptive statistics, which included frequencies of correct and incorrect responses to 
each of the 15- pre/post-test questions, and means with standard deviations for any continuous 
variables.  A paired-sample t-Test was used to determine if there was a significant change in 
participants’ mean score following the completion of the LEARN education module designed to 
increase participants’ knowledge of our HAPU prevention guidelines. 
In Phase II, as mentioned previously, inpatient units from Bethesda North, Good 
Samaritan, and Bethesda Butler, were assessed after 4 weeks of Phase I for 65% or greater 
completion of the LEARN didactic.  The units that achieved 65% or greater were included in the 
medical record review.  Sixty-five medical records were equally divided between the 5 
participating units, thus 13 medical records were reviewed on each participating unit.  The 
measured variables on the Sacral Silicone Foam Dressing Algorithm Fidelity Scale (Appendix 
D) included 1) completion of an admission skin assessment, 2) the nursing selected Mepilex® 
application criteria, 3) pressure ulcer prevention interventions, 4) maintenance of Mepilex® 
dressing, 5) dressing interventions during shift, 6) documentation of skin site assessment, and 7) 
initiation of plan of care.  Each of the measured items were coded as 0=Incomplete, 1= 
Complete, and 2= Not Applicable.  A percentage, from the seven items documented, was 
calculated to produce a total percent score for adherence.  The total score was converted into a 1 
to 5 Likert scale with a rating of 5 indication excellent adherence and a rating of 1 representing 
complete or almost complete lack of adherence.  A Likert score of 5 indicated adherence for 90% 
or more of the expected documentation in the medical record, 4 indicated 70% to 89% of 
expected documentation, 3 indicated 50%-69% of expected documentation, 2 indicated 11% to 
49% of expected documentation, and 1 indicated 10% or less of expected documentation. 
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On the Sacral Silicone Foam Dressing Algorithm Fidelity Scale (Appendix D), adherence 
item number two, the “nursing selected Mepilex® application criteria”, addresses the nurses’ 
documentation of patient-specific and hospital-specific variables admissible for Mepilex® 
application.  Twenty-one variables were measured as 1) surgical procedure or cumulative 
surgeries lasting greater than 4 hours per current admission, 2) cardiopulmonary arrest or rapid 
response this admission, 3) vasopressor administration, 4) body mass index greater than 40 or 
less than 18, 5) mechanical ventilation, 6) quadriplegia or spinal cord injury, 7) drive lines 
including ventricular assist devices (VAD), intra-aortic balloon pump (IABP), or extracorporeal 
membrane oxygenation (ECMO), 8) Rotoprone, 9) Continuous Renal Replacement Therapy 
(CRRT), 10) continuous or bi-level positive airway pressure (CPAP/BiPAP), 11) Braden score 
13 or less, 12) past history of pressure ulcers, 13) sedation or paralytic administration greater 
than 12 hours, 14) restraints, 15) weeping edema/Anasarca, 16) traction, 17) patient age greater 
than 65 years old, 18) diabetes mellitus, 19) bed rest, 20) malnutrition defined as prealbumin 
<20mg/dl, Albumin <2.5mg/dl, nothing by mouth (NPO) greater than 3 days), and 21) 
fecal/urinary incontinence controlled by indwelling catheter/fecal management device.   
In Phase II, descriptive statistics included frequency of the categorical variables measured 
in the adherence of nursing documentation, and means with standard deviation for all continuous 
variables.  A one-way between group analysis of variance (ANOVA) was conducted to explore 
the impact of hospital and unit location on the percent of medical record documentation 
completed.   Statistical analyses were performed with an alpha level p=<0.05, and were 
considered statistically significant.  All analyses were performed using SPSS IBM statistics 
version 22.0 (IBM Corp., Armonk, NY, USA). 
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Results 
Sample Description 
 Table 1 provides a description of our sample that completed the pre/post-test 
questionnaire.  A total of 1,100 nurses from Bethesda North, Good Samaritan, and Bethesda 
Butler voluntarily completed the demographic assessment.  The majority of our sample was 
female (92.2%), falling into the age rage of 46-55 years (27.2%), and Caucasian (92%).  When 
evaluating work tenure, nursing specialty, and highest level of education, majority of our 
participants selected 0-5 years work tenure (26.3%), with most of our nurses working within 
surgical or peri-operative services (26.7%) followed by medical-surgical nursing (23.8%).  As 
expected our participants mostly obtained a Bachelors of Science (BSN) nursing education at 
49.4% followed by Associate Degree Nurses (ADN) at 45.1%. 
Impact of Pre and Post-Test Assessment on Nursing Knowledge  
A total of 1,182 nurses completed the voluntary pre-test questionnaire and 1,514 
participated in the post-test questionnaire. A paired-sample t-Test was conducted to evaluate the 
impact of the LEARN pressure ulcer education didactic on participants’ mean scores on our 15-
question pre and post-test analysis.  Table 2 shows the impact of the LEARN education of the 
pressure ulcer prevention pre and post-test scores.  There was a statistically significant 
improvement in the mean scores from the pre-test (Mean= 56.0, SD= 30.3) to the post-test 
(Mean= 85.4, S.D.= 9.6), t(14)= 4.86, p < .000.  The mean increase in scores was 29.5 between 
the two tests.  Each of the 15-questions was evaluated for comparison of the pre-test score to the 
post-test score correct response.  Using only the frequency of correct responses for each 
question, Figure 1 depicts the difference from the pre-test to the post-test.  With only one data 
point, we are unable to determine statistical significance, however, an improvement in post-test 
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score was appreciable for all 15 questions.  Six of the 15 questions demonstrated a 30% or 
greater change between the pre-test score and the post-test score (Table 3). 
Documentation Adherence Monitoring 
  Sixty-five medical records (n=65) were reviewed between Bethesda North Hospital (BN), 
Good Samaritan Hospital (GSH), and Bethesda Butler Hospital (BB).  Five inpatient units met 
criteria for review including the Cardiovascular ICU (BN), Medical-Surgical ICU (BN), 
Neurology ICU (GSH), Surgery/Peri-Surgical Services (GSH), and In-Patient unit (BB).  Table 4 
provides the description of medical records reviewed per hospital and unit location.  Twenty-six 
medical records were reviewed from Bethesda North (40%) and Good Samaritan (40%) 
Hospitals, and 13 medical records were reviewed from Bethesda Butler Hospital (20%).  From 
the 65 medical records, the percent of completed documentation ranged from 0 to 100%, with an 
average percent completed of 62.2% (S.D.= 29.9).  A one-way between group analysis of 
variance was conducted to explore the impact of hospital and unit location on the percent of 
medical record documentation completed.  There was a statistically significant variance in mean 
percent of documentation completed for the three hospitals, F (2, 62)= 5.6, p= .006 (Table 5).  
Despite the significant difference the actual difference in mean percent completion scores was 
relatively small.  Post-hoc comparisons using Tukey HSD test indicated the difference between 
mean scores by location for Bethesda North (M=75.81, S.D. 18.4), being significantly different 
than the mean score from Good Samaritan Hospital (M=50.0, S.D. 32.1, p= .004), but were not 
significantly different than Bethesda Butler Hospital (M=59.3, S.D.=34.3, p= .201) (Table 5).  
Similarly, when looking at each individual units included in this study, the one-way analysis of 
variance determine the mean percent completion scores per unit was different, F (4, 60)= 2.8, p= 
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.017.  However, when addressing the mean percent difference between units none were 
statistically different from each other. 
We developed a 5-point Likert scale to categorize the percent documentation that was 
complete per medical record (Figure 2).  Our results showed 72% of the medical records 
achieved 50% or greater completion of the required documentation, with most medical records 
(n=28) achieving a Likert rating of 4 indicating 70%-89% completion.  Looking more 
specifically at the Mepilex® protocol interventions, our study found that 30.8% (n=20) of the 
medical record documentation indicated the patient did not meet application criteria for the 
Mepilex® dressing (Table 6). Just over half the charts at 50.8% (n=33) met criteria and a 
prophylactic Mepilex® was indicated, whereas, 16.9% of patients met criteria for the Mepilex® 
dressing, however the nurse missed the criteria and no Mepilex® was used.  Only 1.5% (n=1) of 
our patients did not meet the Mepilex® application criteria, but erroneously a Mepilex® was 
applied anyway (Table 6).  To explore the relationship between the Mepilex® application criteria 
and the hospital location and unit a Chi-square test for independence was attempted, however, 
violation of the minimum cell frequency assumption prohibited accurate results and was not 
concluded. 
The measured variables on the Sacral Silicone Foam Dressing Algorithm Fidelity Scale 
included items 1) completion of an admission skin assessment, 2) the nursing selected Mepilex® 
application criteria, 3) pressure ulcer prevention interventions, 4) maintenance of Mepilex® 
dressing, 5) dressing interventions during shift, 6) documentation of skin site assessment, and 7) 
initiation of plan of care.  Each of these variables were measured as 0= Incomplete, 1= 
Complete, or 2= Not Applicable, and are described in Table 7.  Figure 5 depicts the adherence of 
nursing documentation with the frequency for completion of each variable measure.  Item 1 had 
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53.8% incompletion of its measure.  Item 1: Completion of an admission skin assessment 
contained two subscales on the Sacral Silicone Foam Dressing Algorithm Fidelity Scale 
including A) a skin assessment was completed on admission and B) if the timely assessment was 
completed within “4 eyes in 4 hours.” When looking at the subscale items, only 1 medical record 
did not complete a skin assessment on admission (subscale A), while 58.5% of the time 
documentation of “4 eyes in 4 hours” was incomplete (subscale B), accounting for the high level 
of item 1 incompletion.  Item 2: Nursing selected Mepilex® application criteria was complete 
72.3% of the time and was our highest completed category.  Item 3: pressure ulcer prevention 
intervention documentation was completed in 47.7% of the medical records.  Item 4 included the 
maintenance of the Mepilex® dressing and measured if the dressing was dated and changed 
every 72 hours or when soiled, and item 5 indicated dressing interventions including peeling 
back the dressing to evaluate sacral skin per shift, changing the dressing, or removal.  Item 4 and 
5 documentation was incomplete in 43.1% of the medical records reviewed, compared to 27.7% 
completion.  Item 6 monitored the sacral skin assessment as “within the defined limits” or if a 
HAPU formed.  Per nursing documentation there were zero HAPUs identified in the 65 medical 
records reviewed, and only 1 individual identified with a pressure ulcer present on admission to 
the hospital.  With that, Item 6 had 52.3% completion of documentation indicating sacral skin 
was assessed and was “within the defined limits.”  Lastly, item 7 measured if the nurse initiated 
the patient’s Plan of Care to include “potential for compromised skin integrity.”  Nursing 
documentation reported item 7 being completed 47.7% of the time. 
Indicators for Mepilex® Application 
 Twenty-one variables were included in the HAPU protocol to initiate application of 
Mepilex® dressings.  Fourteen of these variables were considered “high-risk” with requiring 
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only 1 criteria present to use the dressing, and 7 were considered “moderate-risk” requiring 5 or 
more cumulatively for Mepilex® dressing application.  In our medical record review, Figure 3 
depicts the frequency at which nurses identified and documented these criteria.  Of the variables 
to select from, bed rest, weeping edema/anasarca, CRRT, Rotoprone, Drive Lines, and 
quadriplegia/Spinal cord injury were variables not selected by the nurse.  The variables selected 
most frequently include patient age being greater than 65 years (26.2%), surgical procedure or 
cumulative surgeries lasting greater than 4 hours per current admission (26.2%), Braden Scale 
Score 13 or less (16.9%), and mechanical ventilation (20%). 
Discussion 
 The purpose of our study was two-fold. Our first goal was to determine if there was a 
change in nursing knowledge before and after an educational didactic about HAPU and the new 
policy changes being implemented.  Second we wanted to determine if there was a change in 
nursing clinical behavior as seen through the adherence of documentation of policy 
interventions.  Previous studies have suggested implementing pressure ulcer prevention policies 
increase nursing knowledge and effectively changed practice behaviors (Pieper & Mattern, 1997; 
Sinclair et al., 2004; Armstrong et al., 2008; Chicano & Drohllshagen, 2009).  Furthermore, 
when pressure ulcer policies are employed and nursing education is provided, pressure ulcer 
incidence and prevalence was reduced (Armstrong et al., 2008; Holmes & Edelstein, 2007; 
Gibbons, Shanks, Kleinhelter & Jones, 2006; Ayello & Lyder, 2006; Catania, 2007; Chicano & 
Drohlshagen, 2009).  Our results indicate that a change in nursing knowledge occurred.  A paired 
sample t-test demonstrated statistically significant differences (p < .000) between correct 
responses on our pre-test and post-test questionnaire, suggesting our LEARN pressure ulcer 
didactic changed the nurses’ knowledge after the intervention. The mean score from our pre-test 
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responses was 56.0% compared to our post-test scores of 85.4% falls within the findings 
supported in the literature.  Studies examining pre/post-test evaluation on change in nursing 
knowledge pertaining to HAPU prevention have demonstrated variable findings.  One study 
indicated a statistically significant improvement (p< .001) in nursing knowledge between a pre-
test, post-test 1, and post-test 2 scores (Sinclair et al., 2004). At a 3-month follow up post-test 2 
indicated a sustained improvement in nursing knowledge compared to the pre-test, but at slightly 
lower rate than the initial post-test 1 results (Sinclair et al., 2004).  Tweed and Tweed (2008) 
examined knowledge scores before and after and education program in a New Zealand medical-
surgical ICU, and showed no significant difference between pre and post-test scores after an 
educational intervention.  Although we have a statistically significant difference between mean 
scores before and after our intervention, we cannot say that our intervention alone caused the 
increase between our scores.  There are potential confounding influences such as years of 
experience in nursing, specialty of nursing, previous knowledge, skill, and experience with 
HAPU prevention that could have contributed to this difference.  Zullkowski et al., (2007) 
reported knowledge scores with significant differences between nurses certified in wound care to 
those who were not (p < .000).  Similarly to certification, Mockridge and Anthony (1999) 
demonstrated that nurses (N=145) in the United Kingdom scored better on pressure ulcer 
knowledge assessment tests if they had higher levels of education.  Tweed and Tweed (2008) 
reported differently, and found no association between their test scores and demographic data 
including the number of years as a nurse, tenure of experience in the ICU, education on pressure 
ulcers, or qualifications such as specialty certifications. 
Studies have revealed that staff nurses often perform poorly on tests measuring 
knowledge of pressure ulcer identification, staging, and prevention (Berquist-Beringer, et al., 
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2009).  A recent survey of 692 nurses found that 70% considered their basic education on 
pressure ulcers to be insufficient.  This study found knowledge and confidence with identifying 
and staging pressure ulcers increased with age and experience, with only 62% of hospital nurses 
feeling confident in their abilities to identify and stage pressure ulcers and with new nurses 
having less than 50% confidence (Ayello, Baranoski, & Salati, 2005; Zullkowski, 2007). 
Berquist-Beringer et al., (2009) assert that pressure ulcer education does improve knowledge, but 
suggests that regular educational updates are warranted for the sustainability and long-term 
understanding of HAPU knowledge and practice standards.  Additional studies supports this 
notion, that improved identification of pressure ulcers and ongoing nursing education to increase 
knowledge and awareness of clinical standards are associated with reduce HAPU incidence rates 
(Young, Evans & Davis, 2003).  Initial nursing education, ongoing updates, and nursing support 
are clearly warranted for the success of implementing new standards of care.  Our pre/post-test 
analysis suggests that our education didactic was successful at changing nursing knowledge, 
however, the long-term implications and sustainability need to evaluated and measured to 
determine the overall effect of implementing our HAPU prevention policy. 
The second aim of this study was to determine if a change in nursing clinical behavior 
was seen through the adherence of documentation of policy interventions.  Our study indicates a 
mean rate of completed documentation in our medical record review of 62.2% (S.D.= 29.9).  
Seventy-two percent of our medical records achieved 50% or greater completion of the required 
documentation.  Our documentation adherence results are slightly lower to the findings found in 
the literature.  Barker et al. (2013) found in medical record audits after implementing a pressure 
ulcer prevention program, showed a high compliance to documentation at a rate greater than 
84%.  Other studies addressing nursing documentation adherence to pain management protocols 
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showed similar findings of 85% adherence, but also found mixed variability in the consistency in 
the type of pain management documentation (Jablonski & Ersek, 2009).  One study 
implementing pressure ulcer policies and upgrading EMR documentation requirements measured 
documentation adherence, and found 99% compliance due to the EMR enabling nurses to 
identify HAPU risk and directing nursing assessment towards specific interventions for HAPU 
prevention (Chicano & Drolshagen, 2009).  In our study we analyzed the mean percent 
documentation score per hospital location and unit to identify if one location or unit had lower 
documentation rates than others.  The mean percent completion score was statistically significant 
per hospital location, but the actual difference in completion scores was only significant between 
Bethesda North and Good Samaritan Hospitals.  Similarly, the mean percent completion score in 
the 5 units included in the medical review were statistically significant, but the difference 
between them was not.  This may suggest that Good Samaritan Hospital had lower mean 
completion rates than Bethesda North and Bethesda Butler hospital, and contributed to the 
overall lower completion scores compared to other studies. 
  Several explanations can be provided to why our results were lower than other studies.  
The first explanation is the LEARN education was not completed by the nurses whose 
documentation was being audited.  This has the potential of introducing misclassification bias 
into the data we collected, as the nurse might have been unaware of how to correctly document 
or the clinical behaviors needed for the HAPU policy.  Second, there is the potential that the 
LEARN education was not successful at changing knowledge or behaviors.  As mentioned in 
Rogers’ Theory of Diffusion of Innovation, participant characteristics and willingness to change 
lie on a continuum of early adopters to laggards (Rogers, 2008).  We do not know the nurses’ 
beliefs or perceptions pertaining to the changes we introduced, or their willingness to complete 
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the required interventions and documentation.  The culture of change may have influenced our 
results.  Last, nursing documentation may not reflect actual practice.  It is possible the nurse 
completed the HAPU protocol assessment, interventions, and maintenance, but the 
documentation was not accurate to the care provided.  Reversely, documentation could have 
indicated the HAPU interventions were followed, but indeed were not delivered to the patient.  
The level of adherence to evidence-based guidelines for pressure ulcer prevention may be 
misleading when just evaluating documentation alone.  
From the medical records reviewed (n=65), 50.8% met criteria for the Mepilex® 
dressing, 30% did not meet criteria thus no Mepilex® was used, 16.9% of patients met criteria 
but the dressing application was missed, and 1.5% did not meet criteria but a Mepilex® was used 
anyway.  In attempts to determine if correct identification of Mepilex® application criteria was 
associated with hospital location or unit, we attempted a chi-square test for independence, but 
violated minimum expected cell frequency assumptions, thus results were inconclusive.  In the 
studies evaluating Mepilex® efficacy, participant selection came from an ICU population 
suggesting higher-acuity of illness, co-morbidity, and the likelihood of more intense hospital-
based interventions such as mechanical ventilation, longer surgical procedures, vasopressor 
administration, etc. (Brindle 2010, Cox, 2011; Brindle & Wegelin 2012; Chaiken, 2012; Walsh 
et al., 2012; Cubit et al., 2013; Santamaria et al., 2013).  In the present study, the cardiovascular 
ICU, medical-surgical ICU, and neurology ICU had the highest percentage of medical records 
indicating the patient met criteria for Mepilex® application.  Whereas, the inpatient unit at 
Bethesda Butler and surgical-services at Good Samaritan Hospital, both had high rates for not 
meeting Mepilex® application criteria.  This may suggest that the application criteria are more 
specific to the critically ill patient population.  Additionally, when evaluating the nurse selected 
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criteria for Mepilex® application, the top selected variables were age being greater than 65 years 
(26.2%), surgical procedure or cumulative surgeries lasting greater than 4 hours per current 
admission (26.2%), Braden Scale Score 13 or less (16.9%), and mechanical ventilation (20%). 
Studies evaluating critically ill patients for predictors of pressure ulcers have similarly found that 
age, vasopressor administration, mechanical ventilation, and length of surgical procedure were 
major contributors to pressure ulcers (Cox, 2011; Aronovitch, 1999; Senturan et al., 2009). 
Limitations 
This study had several important limitations.  First, timing of the LEARN education and 
the EMR documentation changes occurred simultaneously, which potentially introduced bias to 
the nursing responses on the pre/post-test analysis.  The potential of having seen the EMR 
documentation changes prior to receiving the LEARN education could have skewed the 
responses from participants, and lead to more favorable responses on the pre/post-test questions 
pertaining to the new Mepilex® protocol and policy changes.  Although there were no specific 
questions related to EMR documentation requirements, the changes to the EMR directed the 
Mepilex® protocol and maintenance, as well as the changes made to TriHealth’s Pressure 
Ulcers: Guidelines for Prevention and Treatment policy.  This might have provided knowledge 
prior to taking the pre-test or post-test. 
Second, the LEARN didactic was provided to a convenience sample of nurses.  Because 
this was a change to hospital policy all nurses were mandated to complete the LEARN didactic, 
and only the pre/post-test analysis were considered voluntary.  Participants self-selected to 
complete the pre/post-test analysis and these scores were not compared to a control group.  This 
introduces potential confounding variables such as pre-existing knowledge, level of experience, 
interest in HAPU prevention, etc., to why nurses participated or didn’t.  The LEARN database 
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provides only total percentages of the responses provided, therefore, in this study it was not 
possible to determine associations between participant demographics to the scores achieved, that 
is, was tenure, years of nursing experience, unit location, etc., an influencing factor of the scores 
achieved?  To strengthen this limitation of this study, we recommend using a time-series 
approach with a non-equivalent control group that would complete the pre/post-test only without 
the didactic intervention to introduce research control.  Additionally, having a study design with 
the capability of associating demographic information to mean scores would help us better 
understand the influence of confounding variables as mentioned above. 
Third, the medical record review was completed retrospectively to determine if the nurse 
completed the appropriate documentation.  This threatened the validity of the data, as the 
Primary Investigator could only collect data for the variables of interest that were previously 
documented.  Documentation in medical records may not reflect actual practice, so level of 
adherence to evidence-based guidelines for pressure ulcer prevention may be misleading.  
Furthermore, data points were subject to the accuracy and completeness of the documenting 
nurse, and as previously mentioned misclassification bias could have contributed to incorrect 
documentation.  Only the primary investigator completed the medical record review, which 
precluded the potential for inter-rater reliability difference and additional misclassification bias 
to the findings.  Another limitation to the medical record review is the small sample size (n=65) 
of records reviewed, which limits the generalizability to other populations. 
Finally, this study described a sample of nurses who completed a educational didactic and 
then observed if the change in nursing knowledge translated into changes in nursing behavior 
through documentation.  The impact of these changes on patient outcomes, particularly HAPU 
incidence and prevalence was not measured.  The impact of screening patients with our high-risk 
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assessment tool were not measured in this study, nor can these findings provide causal 
effectiveness of our assessment tool in identifying patients at-risk for HAPU reduction.  Our 
findings may not be generalizable to other facilities or populations outside of acute care inpatient 
settings. 
Implications to Clinical Practice 
 It is abundantly evident and supported that pressure ulcer prevention strategies are 
imperative for HAPU reduction, improved quality outcomes, and financial survival in healthcare 
organizations.  Findings from the reviewed studies suggest that pressure ulcer education does 
improve knowledge, but regular educational updates are needed for the sustainability and long-
term understanding of HAPU knowledge and practice standards.  Additionally, studies suggest 
early identification of HAPU risk and ongoing nursing education to increase knowledge of 
clinical standards were associated with reduce HAPU prevalence.  This HAPU prevention 
program may provide nurses with the education necessary to proactively identify acutely ill 
patients at-risk for HAPU and intervene with prevention strategies.  The long-term success of 
this program will need to provide future support and education to the bedside nurse. This will 
drive and sustain the changes in practice.   
Medical record audits to measure documentation adherence are not new to healthcare.  
Audits help us determine areas for improvement in the care we provide to ultimately produce 
better patient outcomes.  The American Nurses Association (ANA) stated that nursing 
documentation needs to be accurate, consistent, timely, and sequential (ANA, 2005). Data from 
this study suggests a need for nursing support to perform the new clinical behaviors and on the 
documentation of these practices.  Our analysis determined a difference in mean completion rates 
between the three hospital locations.  With this difference, it is recommended efforts be directed 
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towards all facilities, but in particular to Good Samaritan Hospital and Bethesda Butler, as they 
produced lower adherence rates compared to Bethesda North.  Our HAPU prevention 
documentation alluded to several areas of incompletion, particularly to the maintenance and 
intervention of the Mepilex® dressing once it was applied to a patient.  Investigating why these 
areas of documentation have low completion rates should be evaluated and possibly adapted to 
meet the needs and ease of use for the nurse.   
Implications to Future Research 
Future research should include studies evaluating the effectiveness of implementing 
HAPU prevention programs including nursing adherence to the policy, nursing satisfaction, and 
the sustainability of implemented changes.  Having replication studies that evaluate protocol 
implementation, such as our protocol implemented at TriHealth, could demonstrate the 
generalizability of this protocol to other healthcare organizations and populations.  It would be 
imperative to demonstrate the sensitivity and specificity of our high-risk assessment tool to prove 
reliability and validity for identifying at-risk patient populations.  We recommend a future study 
that determines these variables to provide statistical support for the use of this tool.   
Another important area to address with future research is the organizational impact on 
HAPU reduction.  Understanding the implications of Mepilex® dressings and our prevention 
protocol on HAPU prevalence and incidence trends, before and after implementing such a 
prevention program, will help demonstrate the success or failure of the goals of this program.  
Additionally, studies could evaluate the cost-benefit implications of reduced HAPU as a result of 
the prevention program using Mepilex® dressings.  While our study focused on the nursing 
participant, the impact on patient outcomes to prevent HAPU formation should further be studied 
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to investigate the perceived improvement in the quality care that is delivered and patient 
satisfaction as a result of our prevention strategies.    
Conclusion 
The goals of our study were to change nursing knowledge and nursing behaviors.  Results 
of this study indicate our LEARN educational didactic of HAPU prevention was successful at 
changing nursing knowledge.  Variable results from our medical record review suggest areas of 
needed improvement in changing nursing behaviors.  Our medical record review revealed 
nursing failure to consistently follow our HAPU prevention guidelines and intervene with 
preventive interventions with the Mepilex® dressing.  While nursing documentation may not 
reflect actual practice behaviors, we feel our medical record review did demonstrate we are in the 
beginning stages of change, and that our efforts for this program should not stop here.  We need 
to continue to provide support to the bedside nurse to sustain these policy changes and find ways 
to improve the adherence to documentation and increase use of the HAPU prevention protocol.  
This is essential for the long-term success of this program, and hopes for improved patient 
outcomes.  Future research including testing of our assessment tool for validity, reliability, and 
generalizability would help provide added support for the use of our assessment tool and this 
program.  A follow-up longitudinal study could compare nursing knowledge and adherence at a 
later time to evaluate the sustainability and long-term outcomes of this program, and furthermore 
analysis of HAPU prevalence rates before and after implementing this program to determine the 
impact of HAPU reduction. 
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Table 1:  Phase I Sample Characteristics 
 
  
 Participants 
(n = 1,100) 
 
 n % 
Gender   
Male 86 7.8 
Female 1,014 92.2 
Age   
18-25 years 82 7.5 
26-35 years 
36-45 years 
46-55 years 
56-65 years 
66-75 years 
>76 years 
290 
217 
299 
186 
17 
9 
 
26.4 
19.7 
27.2 
16.9 
1.6 
.8 
 
Ethno/Cultural   
Caucasian/White 1,012 92.0 
African American/Black 42 3.8 
Hispanic/Latin American 7 .6 
Asian 
Other 
10 
29 
.9 
2.6 
Work Tenure    
0-5 years 294 26.7 
6-10 years 
11-15 years 
211 
116 
19.2 
10.6 
16-20 years 
21-25 years 
26-30 years 
31-35 years 
36-40 years 
>41 years 
 
90 
100 
88 
92 
78 
31 
8.2 
9.1 
8.0 
8.4 
7.1 
2.8 
Nursing Specialty   
Medical Surgical 262 23.8 
Critical Care 209 19.0 
Emergency Department 102 9.3 
Oncology 32 2.9 
Surgical Services/Perioperative Services 
Long-Term/Inpatient Rehabilitation 
Telemetry 
Transitional Care 
Psychiatric Care 
294 
14 
155 
5 
27 
 
26.7 
1.3 
14.1 
.5 
2.5 
 
Highest Level of Education   
Associate Degree Nursing (ADN) 496 45.1 
Bachelors of Science (BSN) 
Master Degree of Nursing (MSN) 
Doctoral Degree (PhD/DNP) 
543 
55 
6 
49.4 
5.0 
0.6 
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Table 3:  
Difference in Mean Scores on Correct Response from Pre & Post-Tests  
 Pre-Test 
(%) 
Post-Test 
(%) 
Difference 
(%) 
 
Question 1 66.7 90.9 
 
24.2 
Question 2 49.5 85.2 35.7 
Question 3 77.6 90.9 13.3 
Question 4 65.7 88.3 22.6 
Question 5 11.9 72.2 60.3 
Question 6 9.8 79.0 69.2 
Question 7 86.3 91.7 5.4 
Question 8 81.5 92.4 10.9 
Question 9 25.2 76.4 51.2 
Question 10 56.4 80.9 24.5 
Question 11 30.8 62.9 32.1 
Question 12 15.1	   88.1 73.0 
Question 13 96.5	   97.5 1.0 
Question 14 91.5	   97.0 5.5 
Question 15 75.0	   88.3 13.3 
Table 2 
Impact of LEARN Education on Pressure Ulcer 
Prevention Pre and Post-Test 
Variable Pre-Test 
(n=15) 
Post-Test 
(n=15) 
Paired Sample 
Correlation 
Paired t-Test 
 Mean S.D. Mean S.D R p  
 
Participant 
Score 
 
56.0 
 
30.3 
 
85.4 
 
9.6 
 
.794 
 
.000 
 
<.000 
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Table 4: 
Phase II Medical Record Review Description 
Hospital n % 
Bethesda North 26 40 
CVICU 13 20 
MSICU 13 20 
Good Samaritan 26 40 
Neuro ICU (12c) 13 20 
Surgery/Peri-
Surgical Services 
13 20 
Bethesda Butler 13 20 
ICU/In-Patient Unit 13 20 
TOTAL 65 100 
CVICU= Cardiovascular Intensive Care Unit 
MSICU= Medical Surgical Intensive Care Unit 
 
 
Table 5:  
 
One-Way Analysis of Variance between Percent Completion and Hospital and Unit Location 
Hospital n % Mean S.D. Mean 
Difference 
Sig 
Bethesda North 26 40 75.8 18.4 25.8 .004 
CVICU 13 20 76.9 21.5   
MSICU 13 20 74.7 15.6   
Good Samaritan 26 40 50.0 32.1 9.3 .590 
Neuro ICU (12c) 13 20 52.7 29.4   
Surgery/Peri-
Surgical Services 
13 20 47.2 35.7   
Bethesda Butler 13 20 59.3 34.4 16.5 .201 
In-Patient Unit 13 20 59.3 34.4   
TOTAL 65 100 62.2 29.9   
CVICU= Cardiovascular Intensive Care Unit 
MSICU= Medical Surgical Intensive Care Unit 
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Table 6: 
Mepilex® Criteria Frequencies per Hospital Unit Location 
   Unit    
 CVICU 
(BN) 
MSICU 
(BN) 
Neuro-ICU 
(GSH) 
ICU/Inpatient 
(BB) 
Surgery 
(GSH) 
TOTAL 
Criteria* n (%) n (%) n (%) n (%) n (%) n (%) 
A 2 (3.1) 1 (1.5) 3 (4.6) 9 (13.8) 5 (7.7) 20 (30.8) 
B 11 (16.9) 11 (16.9) 7 (10.8) 1 (1.5) 3 (3.6) 33 (50.8) 
C 0 (0) 0 (0) 3 (4.6) 3 (4.6) 5 (7.7) 11 (16.9) 
D 0 (0) 1 (1.5) 0 (0) 0 (0) 0 (0) 1 (1.5) 
*Criteria: 
A= No Mepilex® criteria met, Mepilex® not applied 
B= Mepilex® criteria met, Mepilex® applied 
C= Mepilex® criteria met, RN missed application, Mepilex® not used 
D= No Mepilex® criteria met, Mepilex® erroneously used 
 
 
 
Table: 7 
Sacral Silicone Fidelity Monitoring Scale Description 
 Incomplete Complete Not Applicable 
 (n) (%) (n) (%) (n) (%) 
       
P1 35 53.8 30 46.2 0 0 
P2 13 20 47 72.3 5 7.7 
P3 14 21.5 31 47.7 20 30.8 
P4 28 43.1 18 27.7 19 29.2 
P5 28 43.1 18 27.7 19 29.2 
P6 29 44.6 34 52.3 2 3.1 
P7 25 38.5 31 47.7 9 13.8 
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Figure 1:  
Difference in Correct Response on Pre and Post-Test Evaluation 
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Figure 2: 
Description of Likert Scale Categorization 
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Figure 3 
Nurse Selected Mepilex Criteria 
 
DM= Diabetes Mellitus 
PMH= Past Medical History 
CPAP/BiPAP= Continuous Positive Airway Pressure/BiLevel Positive Airway Pressure 
CRRT= Continuous Renal Replacement Therapy 
Quad/Spinal Cord= Quadriplegia/Spinal Cord Injury 
BMI- Body Mass Index 
Arrest/RR= Cardiopulmonary Arrest/Rapid Response 
Surgery= Surgical procedure or cumulative surgeries lasting greater than 4 hours during current admission
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Figure 4: 
Adherence of Nursing Documentation 
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HAPUs are a preventable problem in healthcare.  Since the 2008 Centers for Medicaid 
and Medicare Services reimbursement changes for Stage III and IV HAPU, healthcare 
organizations have increased awareness for HAPU prevention through provider and patient 
education, updating preventive skin care products and devices, and implementing prevention 
protocols.  The improved awareness and innovative practices has brought HAPU to the forefront, 
and has yielded successful reduction of HAPUs in many organizations.  Evidence-based 
recommendations suggest that healthcare organizations utilize HAPU screening tool to assess all 
patients for pressure ulcer risk, and to implement protocols to direct providers to prevent risk 
with nursing interventions.  These protocols and interventions equate to improved patient-family 
centered care, patient outcomes, and HAPU reduction. In manuscript one, a review of the 
literature evaluating Mepilex® dressings as an additional preventive HAPU therapy was 
discussed.  Although, results are varied, the Mepilex® dressing was successful at reducing 
HAPU prevalence or incidence in the populations to whom the dressing was applied 
prophylactically.  It is recommended that Mepilex® dressings not replace traditional preventive 
standards of care, but as an adjunctive therapy for those a high-risk, or when traditional standards 
of care are insufficient at HAPU prevention.  Evidence-based recommendations from these 
articles support the research designed in Manuscript two.  Manuscript two examined high-risk 
patient-specific and hospital-specific variables that increase risk for HAPU formation in the 
Intensive Care Unit (ICU) population.  These identified patients received the additional treatment 
of prophylactic Mepilex® dressings.  Findings suggest that individuals with mechanical 
ventilations, restraint use, continuous renal replacement therapy, and sedation or paralytic 
administration were more likely to have HAPUs.  Additionally, our findings suggest that 
individuals with respiratory or cardiac diagnoses on admission were more likely to have HAPUs 
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than their referents, and when looking at the high-risk variables, individuals with 5 or greater 
high-risk variables were at increased risk for HAPU.  Among the 47 participants with Mepilex® 
dressing applied preventively, HAPU incidence varied between the sacral skin location and any 
other skin location; two HAPUs occurred on the sacral skin area, while 20 HAPU developed on 
other skin locations.  From this study, we recommend for organizations to include a high-risk 
screening tool specific to high-risk variables, and the use of prophylactic Mepilex® dressings 
may be beneficial to this population.  Manuscript three evaluates the implementation of a HAPU 
prevention program including a high-risk screening tool, preventive Mepilex® intervention, and 
the adherence to nursing documentation.  The purpose was to determine a change in nursing 
knowledge and behavior as a result of the implemented HAPU prevention protocol.  This 
descriptive study suggests that our LEARN educational didactic on TriHealth’s new HAPU 
prevention standards of care were effective and resulted in a statistically significant change in 
our nurses knowledge.  Our evaluation of medical records to ascertain if nurses were consistently 
documenting their clinical behaviors, indicating nurses are providing HAPU screening and 
applying and maintaining Mepilex® dressings, however, they were not consistently adhering to 
the protocol, specifically in the daily maintenance and evaluation of the Mepilex® dressing.   
Our findings overall suggest that TriHealth has begun implementing our policy change and 
HAPU prevention, but a great need exists to provide continued education and support to the 
bedside nurse on the Mepilex® dressing to help reinforce the new guidelines.  Future studies are 
warranted to evaluate the impact of HAPU reduction before and after this program was 
implemented, studies to determine the reliability and validity of our high-risk assessment tool, 
and ongoing evaluation of nursing knowledge and adherence to this program. 
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Appendix A 
TriHealth’s Pressure Ulcers: Guidelines for Prevention and Treatment 
 
 
NURSING POLICY, PROCEDURE & GUIDELINES MANUAL 
 
 
TITLE: PRESSURE ULCERS:  GUIDELINES FOR PREVENTION 
AND TREATMENT 
Skill Level: RN  
Policy Statement: To provide the maintenance or improvement in skin integrity by utilizing 
evidence-based practice through optimal nutritional support, optimal 
tissue load management, and nursing care interventions.  This will be 
achieved through the use of a risk assessment tool and treatment 
protocols developed to ensure these best practices 
Definitions:  CWOCN- Certified Wound Ostomy Continence Nurse 
 WCC- Wound Care Certified  
 
Procedure:  
1. Risk Assessment: 
• The Braden Risk Assessment Scale for the Prediction of Pressure ulcers is a tool that 
identifies patients’ risk for pressure ulcer development.  Based on the risk score specific 
interventions will be implemented. 
• The Braden Scale will be completed with the initial assessment and daily except in the 
following areas:  Special Care Obstetrics, Mother/Baby, Labor & Delivery.  AWHONN1 
NeoNatal Skin Condition Score will be completed in the Neonatal Intensive Care Unit 
and Special Care Nursery.   
• Patients will be reassessed daily, with change in condition, when a transfer occurs, or 
after prolonged immobility due to a procedure or surgery. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  AWOHNN-­‐	  Association	  of	  Women’s	  Health,	  Obstetric,	  and	  Neonatal	  Nursing	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2. Prevention of Pressure Ulcer Guidelines:  Refer to Patient Care Guidelines under   
 “Pressure Ulcer Prevention” on Linknet, Clinical>Nursing>Clinical Practice> Skin, 
Wound, Ostomy. Braden Guidelines: 
• For Braden score of 18 or less, initiate the following PRESSURE ULCER PREVENTION 
interventions specific to your patient’s needs, and “Potential for Compromised Skin 
Integrity” plan of care in Electronic Medical Records (EMR). 
• Pressure Ulcer Prevention Interventions for Braden score 18 or less (see Appendix A): 
Nursing Standards of Care 
! Inspect and document skin every shift 
! Do not massage over bony prominences or red areas 
! Show video, “Prevention of Pressure Ulcers” to patient and family 
(available on GetWell Network). 
! See Pressure Ulcer Prevention Guidelines on LinkNet 
• On admission to the hospital, unit, or transfer implement the sacral silicone foam 
dressing (Mepilex®) prevention protocol.  See Sacral Silicone Foam Dressing 
(Mepilex®) Guidelines (see Appendix B). 
 
3. Treatment of Pressure Ulcers: 
• Two RNs will complete a head to toe skin assessment within four hours of admission 
and/or transfer to prospective unit (“4 eyes in 4 hours”).  The RN will document 
completion of “4 eyes in 4 hours” and all findings in a nursing communication note or 
appropriate Wound LDA. 
• The RN will assess the patient’s skin every shift and will document the condition of 
any/all wound(s) with each dressing change.   
• Wound measurements will be documented by the RN on initial assessment, every 7 
days, and with significant changes, i.e., deterioration or sharp debridement, if wound(s) 
deteriorates, the RN will document a wound assessment, re-measure the wound, and 
collaborate with the physician and notify/consult (or re-consult) the CWOCN/WCC.   
• If a surgeon is currently treating patient’s wound(s), the wound care consult must come 
from that surgeon. 
• The RN will collaborate with the physician to utilize the Wound Care Order Set, Wound 
LDA, and complete the Pressure Ulcer Documentation Form in the EMR for pressure 
ulcers that are present on admission (POA) and/or hospital acquired pressure ulcers 
(HAPU). 
• The CWOCN/WCC will be consulted based on the wound care order set, or with a 
physician order.  The CWOCN/WCC will provide a focused assessment on the 
anatomical location the consult was received on. 
• The CWOCN/WCC will evaluate wounds within 72 hours of receiving the referral. 
• Reassessment by the CWOCN/WCC will be based on individualized patient needs and 
documented in EMR consult notation. 
 
 
Author: TriHealth Skin Care Committee  
 See contact:  Patti Burke, RN, CWOCN 
	  
101	  
	  
 Maryann Lancaster, RN, BSN 
Competency: Mosby- Pressure Ulcer Prevention and Treatment 
 
Approval:   
 Practice Council date 
    
 Site Chief Nursing Officer, Bethesda North Hospital date 
    
 Site Chief Nursing Officer, Good Samaritan Hospital date 
References (AMA format):  
 
Ayello E.A., Sibbald R.G. (2008).  Prevention pressure ulcers and skin tears.  In:  E. Capezuti, 
D, Zwicker, M. Mezey, T. Fulmer (ed.). Evidence-Based Geriatric Nursing Protocols for Best 
Practice.  (pp. 403-429) 3rd ed.  New York:  Springer Publishing Company. 
Brindle TC (2010) Outliers to the Braden Scale: Identifying high-risk ICU patients and the results 
of prophylactic dressing use. The World Council of Enterstomal Therapists 30 2-8. 
Brindle TC, Wegelin JA (2012) Prophylactic dressing application to reduce pressure ulcer 
formation in cardiac surgery patients. Journal of Wound Ostomy and Continence Nursing 39 
133-142. doi: 10.1097/WON.0b013e318247cb82 
Chaiken N (2012) Reduction of sacral pressure ulcers in the intensive care unit using a silicone 
border foam dressing. Journal of Wound Ostomy Continence Nursing 39 143-145. doi: 
10.1097/WON.0b013e318246400c 
Cubit K, McNally B & Lopez V (2012) Taking the pressure off in the emergency department:  
Evaluation of the prophylactic application of a low shear, soft silicon, sacral dressing on high risk 
medical patients.  International Wound Journal.  Advanced online publication. doi: 
10.1111/j.1742-481X.2012.01025.x  
Wound,Ostomy and Continence Nurses Society (WOCN Society). (2011). Incontinence 
Associated Dermatitis (IAD): Best Practice for Clinicians. Mt. Laurel (NJ). 
Institute for Clinical Systems Improvement (ICSI). (2013). Pressure ulcer prevention and 
Treatment.  Retrieved July 31, 2013 from www.icsi.org/guidelines 
National Pressure Ulcer Advisory Panel (NPUAP). (2009). International Guideline Prevention 
and Treatment of Pressure Ulcers: Clinical Practice Guidelines.  National Pressure Ulcer 
Advisory Panel & European Pressure Ulcer Advisory Panel. www.npaup.org 
	  
102	  
	  
National Quality Measures Clearinghouse (NQMC). (2013).  Pressure ulcer prevention and 
treatment protocol: percentage of patients with documentation in the medical record indication a 
risk assessment (using the Braden Scale or Braden Q) was complete upon admission.  
Retrieved September 4, 2013 from www.ahrq.org 
Pressure Ulcers Staging Revised by NPUAP. (2007).  Retrieved January 8, 2009, from 
http://www.npuap.org/pr2 
Santamaria N, Gerdtz M, Sage S, McCann J, Freeman A, Vassiliou T, De Vincentis S, Ng AW, 
Manias E, Liu W & Knott J (2013) A randomized controlled trail of the effectiveness of soft 
silicone multi-layered foam dressings in the prevention of sacral and heel pressure ulcers in 
trauma and critically ill patients: the border trial.  International Wound Journal, Advanced online 
publication. doi: 10.1111/iwj.12101 
Walsh N S, Blanck AW, Smith L, Cross M, Andersson L & Polita C (2012) Use of a sacral 
silicone border foam dressing as on component of a pressure ulcer prevention program in an 
intensive care unit setting. Journal of Wound Ostomy and Continence Nursing 39 146-149. doi: 
10.1097/WON.0b013e3182435579 
Wound, Ostomy, and Continence Nurses Society (WOCN). (2010). Guideline for prevention and 
management of pressure ulcers. (WOCN clinical practice guideline series; no.2). Mount Laurel 
(NJ). 
Evidence Table Attached: See separate form. 
 
Implemented: 8/14 
Reviewed/Revised: 8/14 
 
 
 
	  
103	  
	  
Appendix	  A:	  	  Pressure	  Ulcer	  Prevention	  Interventions	  
	  
Braden Category Intervention 
Sensory Perception • Assess patient for ability to detect and express pain, 
pressure, or need for repositioning 
• Assess patient perception of biomechanical equipment 
(i.e. SCDs, ETT, Foley, monitoring lines, etc). Remove or 
reposition devices per standard of care, to prevent device 
related pressure. 
Moisture • Skin care products/barrier creams 
• Moisturize dry skin daily 
• Clean urine/feces with incontinence cleanser (not soap) 
• Use incontinence devices when needed to contain fecal 
and/or urinary drainage 
• Protect intact skin from fecal and/or urinary incontinence 
using a moisture barrier  
• Protect open skin from frequent fecal and/or urinary 
incontinence using a moisture barrier with zinc  
• Use adult diapers if needed when patient is out of bed 
and/or during transfers 
• Do NOT place chux for incontinence (see above) 
Activity & Mobility • Use positioning devices as needed.  Refer to TriHealth 
Position/Pressure Redistribution Device Algorithm 
• Turn every 2 hours and as needed 
• Float heels with pillows under knees and lower legs.  DO 
NOT put heels on pillow 
o Boots" refer to Heel Lift Boot Algorithm 
• Use pillows only between bony prominences DO NOT use 
sheets, towels, or blankets 
•  Limit sitting to 2 hours at a time 
• Teach patient to shift weight every 15 minutes 
• Use pressure redistribution chair cushions when sitting 
(Geomatt) 
o Do NOT use donut-type device 
• Keep the head of the bed less than 30 degrees unless 
medically contraindicated 
• See algorithm for specialty bed needs 
o Use flat sheet on specialty bed mattresses 
o Use maxiflo pad on low air loss mattresses 
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• Consider PT/OT consult 
Friction & Shear • To prevent skin tears/friction, avoid pulling extremities 
when moving patient, use one pad and avoid wrinkles 
• Do NOT use chux under patient (except for short term 
procedures as needed) 
Nutrition • Consider Dietary consult 
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Appendix B:  Sacral Silicone Foam Dressing (Mepilex®) Algorithm 
Nursing Standards of Care: 
-Provide skin assessment in 4 hours- See Pressure Ulcers:  Guidelines for Prevention and Treatment> 
Procedures>Item 3 on LinkNet 
-Implement pressure ulcer prevention interventions per guidelines 
-Evaluate patient for use of Sacral Silicone Foam Dressing (Mepilex®)  
o Apply sacral silicone foam dressing per protocol criteria (see criteria below) 
o Date/time/initial dressing & “P” for prevention 
o Peel back sacral silicone foam dressing (Mepilex®) and inspect under skin every shift 
assessment 
o Peel back sacral silicone foam dressing (Mepilex®) top down, to keep distal seal 
intact—will help prevent peeling. 
o Document sacral silicone foam dressing (Mepilex®) application on the PUP section of Daily 
Care/Safety  
o Document Site Assessment and Interventions 
o WDL:  Within Defined Limits 
o Exceptions to WDL:  See wound LDA 
o Change sacral silicone foam dressing (Mepilex®) every 72 hours or when soiled 
o DO NOT use on patients with uncontrolled incontinence 
o If sacral silicone foam dressing (Mepilex®) interferes with surgical site integrity, may post-
pone dressing application until completion of surgery and/or apply different shape/size 
dressing 
o PUP interventions are to be discussed in nursing rounds, SBAR reporting at shift change, for 
procedures, and transfers 
CRITERIA FOR APPLYING SACRAL SILICONE FOAM DRESSING (Mepilex®) 
AUTOMATICALLY APPLY MEPILEX® IF 1 OR MORE PRESENT 
# Surgical procedure or cumulative surgeries lasting greater than 4 hours per current admission  
# Cardiopulmonary arrest or rapid response this admission  
# Vasopressor(s) administration  
# BMI: greater than 40 or less than 18 
# Mechanical ventilation  
# Quadriplegia or Spinal Cord Injury 
# Drive Lines (LVAD, RVAD, IABP, ECMO) 
# Rotoprone 
# CRRT 
# CPAP/BIPAP 
# Braden Score: 13 or less    
# Past history of pressure ulcers 
# Sedation/Paralytics greater than 12 hours 
# Restraints 
APPLY MEPILEX® IF 5 OR MORE PRESENT: 
# Weeping edema/Anasarca 
# Traction 
# Age greater than 65 y.o.       
# Diabetes Mellitus 
# Bed Rest 
# Malnutrition (Prealbumin: <20, Albumin: <2.5, NPO greater than 3 days) 
# Fecal/urinary incontinence controlled by indwelling catheter/fecal management device 
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Appendix B 
Letter of Approval from TriHealth IRB 
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Appendix C 
Pre-Test/Post-Test Questionnaire 
1. The	  head	  to	  toe	  skin	  assessment	  “4	  eyes	  in	  4	  hours”	  is	  best	  defined	  as:	  
a. Assessment	  of	  patient’s	  skin	  by	  4	  unit	  staff	  on	  admission	  and	  4	  hours	  later	  
b. Assessment	  of	  patient’s	  skin	  by	  2	  registered	  nurses	  within	  4	  hours	  of	  admission	  to	  their	  
unit	  
c. Assessment	  of	  patient’s	  skin	  by	  2	  unit	  staff	  personnel,	  including	  registered	  nurses	  and	  
patient	  care	  assistants,	  within	  4	  hours	  of	  patient	  admission	  
d. Assessment	  of	  patient’s	  skin	  by	  2	  unit	  staff	  personnel,	  including	  registered	  nurses	  and	  
patient	  care	  assistants	  on	  admission	  and	  4	  hours	  later	  
	  
2. Mrs.	  White	  is	  a	  67-­‐year	  old	  patient	  that	  was	  admitted	  through	  the	  Emergency	  Department	  with	  
abdominal	  pain	  with	  1	  week	  of	  nausea,	  vomiting,	  and	  diarrhea.	  	  She	  is	  dehydrated	  and	  reports	  
not	  being	  able	  to	  eat	  of	  drink	  much	  over	  the	  past	  few	  days.	  	  She	  is	  alert	  and	  oriented,	  very	  weak	  
and	  has	  been	  bed	  ridden	  for	  past	  3	  days	  with	  incontinence	  several	  times	  daily.	  	  What	  is	  her	  
Braden	  Score	  Risk?	  
a. Braden	  Score	  <18-­‐	  High	  Risk	  
b. Mrs.	  White	  does	  not	  meet	  criteria	  for	  Braden	  Score	  assessment	  
c. Braden	  Score	  >18-­‐	  Low	  Risk	  
d. Braden	  Score	  >18-­‐	  High	  Risk	  
	  
3. Which	  of	  the	  following	  are	  not	  acceptable	  prevention	  intervention	  strategies	  for	  patients	  
determine	  at-­‐risk	  for	  pressure	  ulcers/	  
a. Use	  skin	  care	  products/barrier	  creams,	  Moisturize	  skin	  daily,	  and	  Protect	  skin	  from	  fecal	  
and/or	  urinary	  incontinence	  
b. Use	  a	  sacral	  silicone	  foam	  dressing	  (Mepilex®),	  use	  heel	  lift	  boots,	  and	  turn	  patients	  
every	  2	  hours	  
c. Use	  adult	  diapers	  to	  control	  incontinence,	  Massage	  red	  areas	  to	  improve	  circulation,	  
Use	  a	  donut-­‐type	  cushion	  while	  patient	  up	  in	  chair	  
d. Assess	  patient’s	  ability	  to	  detect	  and	  express	  pain,	  pressure,	  and	  need	  for	  repositioning,	  
Float	  heels	  with	  pillows	  under	  knees,	  teach	  patient	  to	  shift	  weight	  every	  15	  minutes	  
	  
4. Skin	  assessment	  should	  be	  completed	  at	  all	  the	  following	  except:	  
a. Admission	  to	  the	  hospital	  
b. Change	  in	  wound	  status	  
c. Transfer	  between	  units	  
d. Discharge	  to	  home	  or	  next	  care	  facility	  
e. After	  prolonged	  immobility	  such	  as	  surgery	  or	  a	  procedure	  
	  
5. A	  patient	  is	  admitted	  to	  your	  unit.	  	  Which	  high-­‐risk	  criteria	  would	  automatically	  indicate	  the	  
need	  for	  a	  preventative	  sacral	  silicone	  foam	  dressing	  (Mepilex®)	  to	  be	  applied	  to	  your	  patient?	  
a. Body	  Mass	  Index	  (BMI)	  38	  
b. Surgical	  procedure	  lasting	  2	  hours	  
c. Continuous	  Positive	  Airway	  Pressure	  (CPAP)	  use	  
d. Age	  greater	  than	  65	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6. How	  many	  low	  risk	  criteria	  would	  be	  required	  to	  apply	  a	  preventative	  sacral	  silicone	  foam	  
dressing	  (Mepilex®)	  to	  your	  patient?	  
a. 5	  or	  more	  
b. 3	  or	  more	  
c. 1	  or	  more	  
d. None,	  they	  are	  low	  risk	  for	  pressure	  ulcers	  
	  
7. The	  correct	  way	  to	  apply	  a	  Mepilex®	  dressing	  to	  the	  sacral	  skin	  is:	  
a. Ensure	  sacral	  skin	  is	  clean,	  peel	  off	  release	  films	  from	  dressing,	  adhere	  to	  patient	  skin	  at	  
top	  of	  gluteal	  cleft	  
b. Spread	  gluteal	  cleft,	  use	  skin	  protectant	  to	  area	  dressing	  will	  be	  applied,	  adhere	  Mepilex	  
with	  distal	  end	  of	  dressing	  at	  top	  of	  gluteal	  cleft,	  smooth	  sides	  over	  buttocks	  
c. Ensure	  skin	  is	  clean,	  spread	  gluteal	  cleft	  and	  locate	  coccyx,	  peel	  off	  center	  release	  film	  
from	  dressing,	  adhere	  to	  patient	  skin	  with	  distal	  end	  of	  dressing	  at	  patient’s	  coccyx,	  
remove	  side	  release	  and	  smooth	  over	  skin	  
	  
8. What	  intervention	  with	  the	  Mepilex®	  dressing	  is	  correct?	  
a. Change	  the	  dressing	  every	  72	  hours	  or	  when	  soiled	  
b. Peel	  back	  and	  assess	  skin	  every	  72	  hours	  
c. Use	  dressing	  on	  patients	  with	  uncontrolled	  fecal	  or	  urinary	  incontinence	  to	  protect	  skin	  
d. Leave	  dressing	  in	  place	  even	  if	  patient	  refuses	  
	  
9. Which	  of	  the	  following	  is	  NOT	  an	  acceptable	  exception	  for	  not	  applying	  a	  Mepilex®	  dressing?	  
a. Uncontrolled	  incontinence	  saturating®	  Mepilex	  dressing	  
b. If	  the	  Mepilex®	  dressing	  interferes	  with	  surgical	  site	  integrity	  
c. Patient	  or	  family	  refusal	  
d. Weeping	  skin	  or	  edema	  (anasarca)	  
e. Allergy	  to	  silicone	  or	  Safetac	  technology	  adhesive	  
	  
10. 	  	  A	  Stage	  III	  pressure	  ulcer	  is	  best	  defined	  as	  
a. Full	  thickness	  tissue	  loss	  with	  bone,	  tendon,	  or	  muscle	  exposure	  
b. Partial	  thickness	  loss	  of	  dermis	  presenting	  as	  a	  shallow	  open	  ulcer	  
c. Full	  thickness	  skin	  loss	  without	  bone,	  tendon,	  or	  muscle	  exposure	  
d. Full	  thickness	  loss	  of	  tissue	  in	  which	  actual	  depth	  of	  ulcer	  is	  uncertain	  because	  wound	  
bed	  is	  obscured	  by	  slough	  and/or	  eschar	  
	  
11. Which	  of	  the	  following	  is	  not	  a	  characteristic	  of	  a	  Stage	  II	  pressure	  ulcer?	  
a. Red	  or	  pink	  wound	  bed	  without	  slough	  
b. Excoriation	  or	  maceration	  of	  the	  skin	  
c. An	  open	  serous	  fluid	  filled	  blister	  
d. Partial	  thickness,	  shallow,	  open	  ulcer	  
	  
12. 	  	  The	  National	  Database	  for	  Nursing	  Quality	  Indicators	  (NDNQI)	  is	  the	  reporting	  agency	  TriHealth	  
submits	  pressure	  ulcer	  prevalence	  rates	  for	  comparison	  to	  other	  facilities.	  	  The	  NDNQI	  
benchmark	  and	  our	  goal	  at	  TriHealth	  is	  to	  maintain	  hospital	  acquired	  pressure	  ulcer	  prevalence	  
below	  what	  percentage?	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a. 1%	  
b. 1.75%	  
c. 2	  %	  
d. 2.5%	  
e. Varies	  month	  to	  month	  
	  
13. Current	  evidence	  based	  practice	  have	  demonstrated	  the	  sacral	  silicone	  foam	  dressing	  to	  be:	  
a. Clinically	  relevant	  for	  the	  reduction	  of	  pressure	  ulcer	  prevalence	  
b. An	  adjunctive	  therapy	  to	  best	  practices	  for	  the	  prevention	  of	  pressure	  ulcers	  in	  
hospitalized	  patients	  
c. Another	  intervention	  combined	  with	  early	  risk	  assessment	  to	  prevention	  pressure	  ulcers	  
d. All	  of	  the	  above	  
	  
14. 	  	  A	  68-­‐year	  old	  female	  patient	  was	  admitted	  to	  the	  ICU	  after	  a	  3-­‐hour	  complicated	  bowel	  
resection.	  	  The	  patient	  is	  intubated	  and	  on	  mechanical	  ventilation,	  she	  has	  levophed	  
(vasopressor)	  and	  a	  sedative	  infusing,	  and	  is	  bedrest	  with	  bilateral	  soft	  wrist	  restraints	  on.	  	  She	  
has	  a	  history	  of	  diabetes,	  hypertension,	  and	  smoking	  1	  pack	  per	  day	  x	  25	  years.	  	  After	  4	  days	  in	  
the	  ICU	  the	  patient	  is	  now	  extubated	  on	  2L	  nasal	  cannula,	  hemodynamically	  stable,	  and	  just	  
started	  a	  clear	  liquid	  diet	  today.	  	  She	  is	  now	  ready	  to	  transition	  to	  a	  surgical	  unit.	  	  On	  her	  
transfer	  you	  complete	  the	  Mepilex®	  risk	  assessment.	  	  Based	  upon	  the	  information	  provided	  
does	  this	  patient	  need	  a	  Mepilex®	  dressing?	  
a. Yes,	  based	  on	  the	  medical	  care	  she	  has	  received	  during	  this	  admission	  she	  continues	  to	  
be	  at	  risk	  for	  pressure	  ulcers	  even	  though	  she	  is	  doing	  better.	  
b. No,	  now	  that	  she	  is	  on	  the	  surgical	  unit,	  she	  does	  not	  meet	  the	  criteria	  for	  a	  Mepilex	  
dressing.	  
c. Not	  sure	  
	  
15. 	  	  Pressure	  ulcers	  present	  on	  inpatient	  admission	  require	  the	  nursing	  team	  to	  do	  all	  of	  the	  
following	  except:	  
a. You	  do	  not	  need	  to	  document	  wounds	  present	  on	  admission,	  because	  they	  occurred	  
outside	  of	  the	  hospital	  and	  we	  are	  not	  responsible	  for	  them	  
b. Notification	  of	  pressure	  ulcer	  or	  wound	  to	  the	  MD	  
c. Wound	  Care	  Team	  consult	  
d. Activate	  Wound	  Care	  Order	  Set	  
e. Document	  all	  POA	  pressure	  ulcers	  and	  wounds	  with	  admission	  assessment	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Appendix D 
Sacral Silicone Foam Dressing Algorithm Fidelity Scale: Inpatient Chart Review Form 
Code Number: ______________________ 
Site: Bethesda North     Good Samaritan 
Unit: ___________________ 
Date Chart Reviewed: ______/_______/_______ 
To be included in chart review, a patient must meet these criteria: 
Admitted to TriHealth and classified with an inpatient status   Yes No 
P1.  Admission Skin Assessment:  A comprehensive head-to-toe skin assessment completed by two staff 
RNs within 4 hours of patient’s admission to the perspective unit (“Four eyes in four hours”).  
A. Skin assessment completed on admission     Yes No 
B. Timely assessment completed in 4 hours of admission to  
the admitted unit?       Yes No 
C. Did patient have a sacral pressure ulcer present on admission  Yes No 
 
 
            Complete   Incomplete 
P2.  Sacral Silicone Foam Dressing Application Criteria:  All applicable sacral silicone foam dressing 
criteria selected by nurse, indicating reason for dressing application. 
A: Mepilex Application Criteria                     RN Document 
High Risk Criteria (1 or more)  Yes  No 
Surgical procedure or cumulative surgeries lasting greater than 4 hours per current admission   
Cardiopulmonary arrest or rapid response this admission    
Vasopressors administration    
BMI: greater than 40 or less than 18   
Mechanical ventilation    
Quadriplegia or Spinal Cord Injury   
Drive Lines (LVAD, RVAD, IABP, ECMO)   
Rotoprone   
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CRRT   
CPAP/BIPAP   
Braden Score: 13 or less   
Past history of pressure ulcers   
Sedation/Paralytics greater than 12 hours   
Restraints   
Moderate Risk (5 or more)   
Weeping edema/Anasarca   
Traction   
Age greater than 65 y.o.   
Diabetes Mellitus   
Bed Rest   
Malnutrition (Prealbumin: <20, Albumin: <2.5, NPO greater than 3 days)   
Fecal/urinary incontinence controlled by indwelling catheter/fecal management device   
Age greater than 65 y.o.   
 
B.  No Mepilex Application criteria were applicable    Yes No 
 
             Complete   Incomplete 
P3.  Pressure Ulcer Prevention Interventions 
A. Has patient received a prophylactic sacral silicone foam dressing  Yes No 
B. PUP sign on door        Yes No 
C. Other (N/A- if not applicable) 
_______________________________________________________________ 
 
            Complete   Incomplete 
 
 
P4.  Maintenance of Sacral Silicone Foam Dressing:  Date of dressing change due; every 72 hours or 
when soiled. 
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A. Date sacral silicone dressing change due documented  Yes No 
 
             Complete   Incomplete 
P5.  Dressing Intervention:  Interventions include new dressing, peeled back for skin inspection, 
dressing removed, or other. 
A. Every shift, were the dressing interventions documented  Yes No 
 
             Complete   Incomplete 
P6.  Site Assessment:  Site assessment is documented as “Within Defined Limits (WDL)” 
Documentation includes skin temperature, moisture level, integrity, and characteristics defined as “Skin 
warm, dry, and intact.  Color appropriate and even.  Skin rises easily and returns to place immediately.  
Skin is free of any lesions, wounds, bruises, abrasions, avulsions, rashes or other abnormalities.”  Or site 
assessment is documented as “Exceptions to Within Defined Limits- see wound LDA” 
A. Was the sacral skin assessment documented    Yes No 
B. If “Exceptions to Within Defined Limits-see wound LDA” was 
selected, did it result in the documentation of a “wound LDA”  Yes No  
 
             Complete   Incomplete 
P7.  Plan of Care:  “Potential for Compromised Skin Integrity” plan of care initiated 
 
A. Did the Best Practice Advisory trigger, result in the nurse adding the 
“Potential for Compromised Skin Integrity” to individualize the patient’s  
Plan of Care?        Yes No 
 
             Complete   Incomplete 
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This portion should be filled out with the Sacral Silicone Foam Dressing Algorithm Fidelity Scale:  
Inpatient Chart Review Forms. Indicate whether the nursing documentation were satisfactory by 
marking each item with a (+) or (-) in the following tally sheet.   
Fidelity Item Complete 
(+) 
Incomplete 
(-) 
P1: Admission Skin Assessment   
P1A   
P1B   
P1C   
P2: Sacral Silicone Foam Dressing 
Application Criteria  
  
P2A   
P2B   
P3:  Pressure Ulcer Prevention 
Interventions 
  
P3A   
P3B   
P3C   
P4: Maintenance of Sacral Silicone Foam 
Dressing  
  
P5:  Dressing Intervention   
P6:  Site Assessment   
P7:  Plan of Care   
 
[(Number Fidelity Items Complete) / (7 total Fidelity Items)] x 100= % complete 
Likert Scale Rating  1 2 3 4 5 
5= 90% or more documentation complete 
4= 70%-89% documentation complete 
3= 50%-69% documentation complete 
2= 11%-49% documentation complete 
1= 10% or less documentation complete  
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